
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC5000044929929CB38.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="intjoncol" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC8997343/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997343/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="International Journal of Oncology" /><meta name="citation_title" content="Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells" /><meta name="citation_author" content="Keitaro Miyake" /><meta name="citation_author_institution" content="Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo 160-0023, Japan" /><meta name="citation_author" content="Naoharu Takano" /><meta name="citation_author_institution" content="Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan" /><meta name="citation_author" content="Hiromi Kazama" /><meta name="citation_author_institution" content="Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan" /><meta name="citation_author" content="Hiroyuki Kikuchi" /><meta name="citation_author_institution" content="Department of Preventive Medicine and Public Health, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan" /><meta name="citation_author" content="Masaki Hiramoto" /><meta name="citation_author_institution" content="Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan" /><meta name="citation_author" content="Kiyoaki Tsukahara" /><meta name="citation_author_institution" content="Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo 160-0023, Japan" /><meta name="citation_author" content="Keisuke Miyazawa" /><meta name="citation_author_institution" content="Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan" /><meta name="citation_publication_date" content="2022/05" /><meta name="citation_issue" content="5" /><meta name="citation_volume" content="60" /><meta name="citation_doi" content="10.3892/ijo.2022.5344" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC8997343/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC8997343/" /><meta name="citation_pmid" content="35348191" /><meta name="DC.Title" content="Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Spandidos Publications" /><meta name="DC.Contributor" content="Keitaro Miyake" /><meta name="DC.Contributor" content="Naoharu Takano" /><meta name="DC.Contributor" content="Hiromi Kazama" /><meta name="DC.Contributor" content="Hiroyuki Kikuchi" /><meta name="DC.Contributor" content="Masaki Hiramoto" /><meta name="DC.Contributor" content="Kiyoaki Tsukahara" /><meta name="DC.Contributor" content="Keisuke Miyazawa" /><meta name="DC.Date" content="2022 May" /><meta name="DC.Identifier" content="10.3892/ijo.2022.5344" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells" /><meta property="og:type" content="article" /><meta property="og:description" content="TP53 mutation is one of the most frequent gene mutations in head and neck squamous cell carcinoma (HNSCC) and could be a potential therapeutic target. Recently, the WEE1 G2 checkpoint kinase (WEE1) inhibitor adavosertib (Adv) has attracted attention because ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997343/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8997343/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Int J Oncol%22[journal]" class="navlink">Int J Oncol</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8997343
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8997343/pdf/ijo-60-05-05344.pdf" class="int-view">PDF (2.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8997343/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8997343/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8997343" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8997343%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="u3KaEoLatTSEIqmPltjkRTadSnSGuiYZ0o1ViMtKzFwLfMT4FcLFbes0VSQMG4hI">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8997343%2F&amp;text=Ricolinostat%20enhances%20adavosertib-induced%20mitotic%20catastrophe%20in%20TP53-mutated%20head%20and%20neck%20squamous%20cell%20carcinoma%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8997343%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997343/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8997343/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/35348191/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8997343/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/35348191/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8997343/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8997343/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Int J Oncol%22[journal]" class="navlink">Int J Oncol</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8997343
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-intjoncol.gif" alt="Logo of intjoncol" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.spandidos-publications.com/ijo" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Int J Oncol.</span> 2022 May; 60(5): 54. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2022 Mar 28. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3892%2Fijo.2022.5344" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3892/ijo.2022.5344</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC8997343</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35348191">35348191</a></div></div></div><h1 class="content-title">Ricolinostat enhances adavosertib-induced mitotic catastrophe in TP53-mutated head and neck squamous cell carcinoma cells</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miyake%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625582089104" co-class="co-affbox">Keitaro Miyake</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Takano%20N%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625570691088" co-class="co-affbox">Naoharu Takano</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>2</sup><sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kazama%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625580419168" co-class="co-affbox">Hiromi Kazama</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kikuchi%20H%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625580417184" co-class="co-affbox">Hiroyuki Kikuchi</a>,<sup>3</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hiramoto%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625580415200" co-class="co-affbox">Masaki Hiramoto</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tsukahara%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625575962480" co-class="co-affbox">Kiyoaki Tsukahara</a>,<sup>1</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miyazawa%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140625575960496" co-class="co-affbox">Keisuke Miyazawa</a><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140625582089104"><h3 class="no_margin">Keitaro Miyake</h3><p>
<sup>1</sup>Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo 160-0023, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miyake%20K%5BAuthor%5D">Keitaro Miyake</a></div></div><div id="_co_idm140625570691088"><h3 class="no_margin">Naoharu Takano</h3><p>
<sup>2</sup>Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Takano%20N%5BAuthor%5D">Naoharu Takano</a></div></div><div id="_co_idm140625580419168"><h3 class="no_margin">Hiromi Kazama</h3><p>
<sup>2</sup>Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kazama%20H%5BAuthor%5D">Hiromi Kazama</a></div></div><div id="_co_idm140625580417184"><h3 class="no_margin">Hiroyuki Kikuchi</h3><p>
<sup>3</sup>Department of Preventive Medicine and Public Health, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kikuchi%20H%5BAuthor%5D">Hiroyuki Kikuchi</a></div></div><div id="_co_idm140625580415200"><h3 class="no_margin">Masaki Hiramoto</h3><p>
<sup>2</sup>Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hiramoto%20M%5BAuthor%5D">Masaki Hiramoto</a></div></div><div id="_co_idm140625575962480"><h3 class="no_margin">Kiyoaki Tsukahara</h3><p>
<sup>1</sup>Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo 160-0023, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tsukahara%20K%5BAuthor%5D">Kiyoaki Tsukahara</a></div></div><div id="_co_idm140625575960496"><h3 class="no_margin">Keisuke Miyazawa</h3><p>
<sup>2</sup>Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Miyazawa%20K%5BAuthor%5D">Keisuke Miyazawa</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140625573893680_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140625573893680_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140625573893680_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140625573893680_ai" style="display:none"><div class="fm-affl" id="af1-ijo-60-05-05344">
<sup>1</sup>Department of Otorhinolaryngology, Head and Neck Surgery, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo 160-0023, Japan</div><div class="fm-affl" id="af2-ijo-60-05-05344">
<sup>2</sup>Department of Biochemistry, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</div><div class="fm-affl" id="af3-ijo-60-05-05344">
<sup>3</sup>Department of Preventive Medicine and Public Health, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="c1-ijo-60-05-05344">Correspondence to: Dr Naoharu Takano, Department of Biochemistry, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan, E-mail: <a href="mailto:dev@null" data-email="pj.ca.dem-oykot@onakatn" class="oemail">pj.ca.dem-oykot@onakatn</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm140625573893680_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2021 Aug 19; Accepted 2022 Mar 10.</div></div><div class="permissions half_rhythm hide" id="idm140625573893680_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> : &#x000a9; Miyake et al.</div><div class="license half_rhythm">This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">Creative Commons Attribution-NonCommercial-NoDerivs License</a>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div><a href="/pmc/articles/PMC8997343/bin/Supplementary_Data.pdf" data-ga-action="click_feat_suppl">Supplementary_Data.pdf</a><span style="color:gray"> (625K)</span></div><div class="small guid">GUID: 73B67D49-468F-470B-AC14-7C6E0CCEB090</div></div></dd></dl><dl data-length="112" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">The datasets used during the present study are available from the corresponding authors upon reasonable request.</p></dd></dl></div><div id="abstract-a.j.b.s" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.j.b.stitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last"><em>TP53</em> mutation is one of the most frequent gene mutations in head and neck squamous cell carcinoma (HNSCC) and could be a potential therapeutic target. Recently, the WEE1 G2 checkpoint kinase (WEE1) inhibitor adavosertib (Adv) has attracted attention because of its selective cytotoxicity against <em>TP53</em>-mutated cells and has shown promising activity in early phase clinical trials. In the present study, it was demonstrated that combined treatment with Adv and a selective histone deacetylase 6 (HDAC6) inhibitor, ricolinostat (RCS), synergistically enhanced cell death induction in four out of five HNSCC cell lines with <em>TP53</em> mutation (CAL27, SAS, HSC-3, and OSC-19), one HNSCC cell line with impaired TP53 function by HPV-infection (UPCI-SCC154), and <em>TP53</em>-knockout human lung cancer cell line (A549 TP53-KO), but not in <em>TP53</em> wild-type A549 cells. Time-lapse imaging showed that RCS enhanced the Adv-induced mitotic catastrophe. Consistent with this, RCS treatment suppressed checkpoint kinase 1 (Chk1) (Ser345) phosphorylation and co-administration of RCS with Adv suppressed cyclin-dependent kinase 1 (Tyr15) phosphorylation along with increased expression of &#x003b3;-H2A.X, a marker of DNA double-strand breaks in CAL27 cells. These data showed that RCS enhanced Adv-induced premature mitotic entry and cell death induction in the mitotic phase. However, although HDAC6 knockdown enhanced Adv-induced cell death with &#x003b3;-H2A.X elevation, HDAC6 knockdown did not repress Chk1 phosphorylation in CAL27 cells. Our data demonstrated that the co-administration of RCS with Adv in HNSCC cells resulted in the suppression of Chk1 activity, leading to synergistically enhanced apoptosis via mitotic catastrophe in a p53-dependent manner. This enhanced cell death appeared to be partially mediated by the inhibition of HDAC6 activity by RCS.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">mitotic catastrophe, p53, head and neck squamous cell carcinoma, adavosertib, ricolinostat</span></div></div><div id="sec-a.k.a" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.k.atitle">Introduction</h2><p class="p p-first">Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world with approximately 800,000 cases being diagnosed every year (<a href="#b1-ijo-60-05-05344" rid="b1-ijo-60-05-05344" class=" bibr popnode">1</a>). Advanced HNSCC shows poor prognosis and resistance to standard therapy consisting of cisplatin. Because 60-80% of HNSCC cases carry a <em>TP53</em> mutation (<a href="#b2-ijo-60-05-05344" rid="b2-ijo-60-05-05344" class=" bibr popnode">2</a>-<a href="#b4-ijo-60-05-05344" rid="b4-ijo-60-05-05344" class=" bibr popnode">4</a>) and human papillomavirus (HPV)-positive HNSCC shows impaired p53 function (<a href="#b5-ijo-60-05-05344" rid="b5-ijo-60-05-05344" class=" bibr popnode">5</a>), therapeutic targeting of the <em>TP53</em> mutation has become a focus of research. Additionally, as p53 is functional in normal somatic cells, targeted therapy against <em>TP53</em> mutations can relieve adverse effects. Thus, owing to its selective cytotoxicity against <em>TP53</em>-mutated carcinoma cells, adavosertib (Adv), a WEE1 G2 checkpoint kinase (WEE1) inhibitor, has been the recent focus of study (<a href="#b6-ijo-60-05-05344" rid="b6-ijo-60-05-05344" class=" bibr popnode">6</a>,<a href="#b7-ijo-60-05-05344" rid="b7-ijo-60-05-05344" class=" bibr popnode">7</a>).</p><p>WEE1 is a kinase that regulates replication stress and cell cycle arrest at the G2/M checkpoint. DNA damage during the S-phase activates WEE1, which in turn phosphorylates cyclin-dependent kinase 1 (CDK1) at Tyr15 to inactivate its kinase activity (<a href="#b8-ijo-60-05-05344" rid="b8-ijo-60-05-05344" class=" bibr popnode">8</a>). Because p53 regulates the G1/S checkpoint (<a href="#b9-ijo-60-05-05344" rid="b9-ijo-60-05-05344" class=" bibr popnode">9</a>), <em>TP53</em>-mutated cells rely on the G2/M checkpoint to arrest the cell cycle to repair their DNA damage. Therefore, Adv treatment of <em>TP53</em>-mutated cells leads to the cells entering M-phase without DNA repair, which in turn causes cell death named mitotic catastrophe. Mitotic catastrophe is a type of cell death characterized by DNA damage, abnormalities in the mitotic apparatus, dysfunction of the mitotic checkpoint, and failure in the occurrence of normal mitosis (<a href="#b10-ijo-60-05-05344" rid="b10-ijo-60-05-05344" class=" bibr popnode">10</a>,<a href="#b11-ijo-60-05-05344" rid="b11-ijo-60-05-05344" class=" bibr popnode">11</a>), but there is no clear definition. As Adv abrogates cell cycle arrest, it was suggested that the co-administration of DNA-damaging drugs with Adv enhances cytotoxicity (<a href="#b7-ijo-60-05-05344" rid="b7-ijo-60-05-05344" class=" bibr popnode">7</a>,<a href="#b12-ijo-60-05-05344" rid="b12-ijo-60-05-05344" class=" bibr popnode">12</a>,<a href="#b13-ijo-60-05-05344" rid="b13-ijo-60-05-05344" class=" bibr popnode">13</a>). In the present study, we sought to identify drug combinations to enhance Adv-induced cytotoxicity without losing selective cell death in <em>TP53</em>-mutated cells.</p><p class="p p-last">It has been reported that histone deacetylase (HDAC) inhibitors induce growth arrest, differentiation, and apoptosis <em>in vitro</em>, and suppress tumor growth in xenograft mouse models with various cancer cell lines including HNSCC (<a href="#b14-ijo-60-05-05344" rid="b14-ijo-60-05-05344" class=" bibr popnode">14</a>-<a href="#b16-ijo-60-05-05344" rid="b16-ijo-60-05-05344" class=" bibr popnode">16</a>). Additionally, HDAC inhibitors have been shown to enhance cytotoxicity in combination with DNA-damaging anticancer drugs (<a href="#b17-ijo-60-05-05344" rid="b17-ijo-60-05-05344" class=" bibr popnode">17</a>,<a href="#b18-ijo-60-05-05344" rid="b18-ijo-60-05-05344" class=" bibr popnode">18</a>) or Adv (<a href="#b19-ijo-60-05-05344" rid="b19-ijo-60-05-05344" class=" bibr popnode">19</a>-<a href="#b21-ijo-60-05-05344" rid="b21-ijo-60-05-05344" class=" bibr popnode">21</a>). We recently reported that ricolinostat (RCS), a selective histone deacetylase 6 (HDAC6) inhibitor, exhibits potent cell growth inhibition in HNSCC cell lines <em>in vitro</em> in combination with the proteasome inhibitor bortezomib (<a href="#b22-ijo-60-05-05344" rid="b22-ijo-60-05-05344" class=" bibr popnode">22</a>). Of note, HDAC6 differs from other HDACs by deacetylating cytoplasmic proteins, including &#x003b1;-tubulin. HDAC6 has also been reported to be involved in the cell cycle via deacetylation of &#x003b1;-tubulin (<a href="#b23-ijo-60-05-05344" rid="b23-ijo-60-05-05344" class=" bibr popnode">23</a>). Additionally, inhibition of HDAC6 has been reported to sensitize cancer cells to DNA-damaging drugs (<a href="#b24-ijo-60-05-05344" rid="b24-ijo-60-05-05344" class=" bibr popnode">24</a>-<a href="#b26-ijo-60-05-05344" rid="b26-ijo-60-05-05344" class=" bibr popnode">26</a>). As the disruption of the cell cycle or DNA damage enhances mitotic catastrophe, in the present study, we assessed the effect of the combined treatment of Adv and RCS on HNSCC cell lines with <em>TP53</em> mutation (CAL27, SAS, HSC-3, Detroit562, and OSC-19) or impaired p53 function by HPV-infection (UPCI-SCC154).</p></div><div id="sec-a.k.b" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.k.btitle">Materials and methods</h2><div id="sec-a.k.b.b" class="sec sec-first"><h3 id="sec-a.k.b.btitle">Reagents</h3><p class="p p-first-last">Adavosertib (AZD1775, MK-1775, hereafter referred to as Adv) was purchased from MedChemExpress. Ricolinostat (ACY-1215, hereafter referred to as RCS) was purchased from Selleck Chemicals. Adv and RCS were dissolved in dimethyl sulfoxide (DMSO) (Wako Pure Chemical Industries) to make the stock solution at a concentration of 10 mM for Adv and 5 mM for RCS. Doxorubicin (DOX) was purchased from Cayman Chemical Co. z-VAD-fmk was purchased from Peptide Institute (Japan).</p></div><div id="sec-a.k.b.c" class="sec"><h3 id="sec-a.k.b.ctitle">Cell lines and culture conditions</h3><p class="p p-first-last">The human oral squamous cell carcinoma cell line CAL27, the human pharyngeal squamous carcinoma cell line Detroit562, human tongue squamous carcinoma cell line UPCI-SCC154, the human breast mammary gland adenocarcinoma cell lines MCF7 and MDA-MB-231, and the human lung adenocarcinoma cell line A549 were purchased from the American Type Culture Collection (ATCC). The human tongue squamous carcinoma cell lines SAS, HSC-3, and OSC-19 cells were obtained from the JCRB Cell Bank (Osaka, Japan). A549 and MCF7 cells possess wild-type <em>TP53</em>. MDA-MB-231, CAL27, HSC-3, SAS, Detroit562, and OSC-19 cells carry mutant <em>TP53</em>. UPCI-SCC-154 cells are HPV-positive and show impaired p53 function. CAL27, Detroit562, MCF7, MDA-MB-231, and A549 cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Biosera) and 1% penicillin/streptomycin solution (Wako Pure Chemical Industries). UPCI-SCC154 cells were cultured in MEM supplemented with 10% FBS and 1% penicillin/streptomycin solution. SAS and OSC-19 cells were cultured in DMEM/F12 medium supplemented with 10% FBS and 1% penicillin/streptomycin solution. HSC-3 cells were cultured in Eagle's minimum essential medium (EMEM) supplemented with 10% FBS and 1% penicillin/streptomycin solution. All cell lines were cultured at 37&#x000b0;C in a humidified incubator containing 5% CO<sub>2</sub> and 95% air. In all experiments, as a control, cells were treated with control medium containing less than 1% DMSO to match the amount of solvent brought in by the drug. All cell line experiments were conducted within 10 passages after thawing. Mycoplasma contamination was tested routinely using the e-Myco&#x02122; Mycoplasma PCR Detection kit ver.2.0 (iNtRON Biotechnology, Inc.).</p></div><div id="sec-a.k.b.d" class="sec"><h3 id="sec-a.k.b.dtitle">Establishment of TP53-KO A549 and TP53-KO MCF7 cells</h3><p class="p p-first-last">TP53-KO A549 cells were established as previously described (<a href="#b27-ijo-60-05-05344" rid="b27-ijo-60-05-05344" class=" bibr popnode">27</a>). Briefly, A549 cells were transfected with pSpCas9 (BB)-2A-Puro (PX459) V2.0 plasmid vector (a gift from Dr Feng Zhang; plasmid cat. no. 48139; Addgene) with the following sequence (5&#x02032;-CAC CGT CCA TTG CTT GGG ACG GCA A-3&#x02032;), selected with puromycin for 2 days, and grown without puromycin to select single colonies. TP53-KO MCF7 cells were also established in the same way.</p></div><div id="sec-a.k.b.e" class="sec"><h3 id="sec-a.k.b.etitle">Establishment of CAL27/H2B-mCherry/AcGFP-&#x003b1;-tubulin cells</h3><p class="p p-first-last">To establish CAL27 cells expressing H2B-mCherry and AcGFP-&#x003b1;-tubulin, CAL27 cells were infected with lentiviruses and positive clones were selected using puromycin and blasticidin. Lentiviruses were produced in 293T cells (ATCC) by transfection of the following plasmids: pMD2.G (gift from Dr Didier Trono: Addgene #12259), psPAX2 (gift from Dr Didier Trono: Addgene #12260), pLenti6-H2B-mCherry (gift from Dr Torsten Wittmann: Addgene plasmid #89766) (<a href="#b28-ijo-60-05-05344" rid="b28-ijo-60-05-05344" class=" bibr popnode">28</a>), and pLenti-AcGFP-&#x003b1;-tubulin. For pLenti-AcGFP-&#x003b1;-tubulin construction, TUBA1A cDNA was cloned into pAcGFP1-Hyg-C1 vector (Takara Bio Inc.), and then, the AcGFP-&#x003b1;-tubulin fused gene was inserted into the pLentiN vector (gift from Dr Karl Munger: Addgene #37444) (<a href="#b29-ijo-60-05-05344" rid="b29-ijo-60-05-05344" class=" bibr popnode">29</a>).</p></div><div id="sec-a.k.b.f" class="sec"><h3 id="sec-a.k.b.ftitle">RNA interference</h3><p class="p p-first-last">For the gene silencing of HDAC6 in CAL 27 cells, HDAC6 siRNA and control siRNA were synthesized as follows (Japan Bio Services Co., Ltd.): siHDAC6#2: sense GCU UAU UUA AGU GUU AAU AdT dT and antisense UAU UAA CAC UUA AAU AAG CdA dC; siHDAC6#3: sense GGU UUU UGC UUU UUC AAC UdT dT and antisense AGU UGA AAA AGC AAA AAC CdG dC; siHDAC6#4: sense GCA UAU GUA AUA AAG UAC AdT dT and antisense UGU ACU UUA UUA CAU AUG CdA dA; control siLuc: sense CUU ACG CUG AGU ACU UCG AdT dT and antisense UCG AAG UAC UCA GCG UAA GdT dT. siRNAs were diluted to 200 nM in Opti-MEM I (Thermo Fisher Scientific, Inc.). Transfection was performed using Lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions. Knockdown (KD) efficiency was assessed using western blotting.</p></div><div id="sec-a.k.b.g" class="sec"><h3 id="sec-a.k.b.gtitle">Assessment of cell death</h3><p class="p p-first-last">The dead cell counts were assessed by staining with propidium iodide (PI) (FUJIFILM Wako Chemical Corp.), and the number of red fluorescent signals was counted using the IncuCyte ZOOM (Sartorius) automated live cell imaging system. The cells were treated with Adv with or without RCS in the presence of PI (2.5 <em>&#x000b5;</em>g/ml) for up to 48 h in 96-well plates in tetraplicate (<a href="#b30-ijo-60-05-05344" rid="b30-ijo-60-05-05344" class=" bibr popnode">30</a>).</p></div><div id="sec-a.k.b.h" class="sec"><h3 id="sec-a.k.b.htitle">Morphological assessment</h3><p class="p p-first-last">The cells were spread on glass slides using a Cytospin 4 Centrifuge (Thermo Fisher Scientific, Inc.) to prepare glass slides, stained with May-Gr&#x000fc;nwald-Giemsa and examined under a digital microscope (BZ-X800; KEYENCE Co.).</p></div><div id="sec-a.k.b.i" class="sec"><h3 id="sec-a.k.b.ititle">Western blotting</h3><p class="p p-first-last">The cells were lysed using RIPA lysis buffer (Nacalai Tesque) added together with a protease and phosphatase inhibitor cocktail (Nacalai Tesque). Equal amounts of proteins (25 <em>&#x000b5;</em>g) were loaded onto the gels (7.5, 10 and 15% gels were used), separated by SDS-PAGE, and then transferred onto Immobilon-P membranes (Millipore Corp.). These membranes were probed with primary antibodies, such as anti-p53 antibody (Ab) (sc-126, 1/1,000), anti-&#x003b2;-actin Ab (sc-47778, 1/1,000), anti-HDAC6 Ab (sc-11420, 1/1,000), anti-acetylated &#x003b1;-tubulin Ab (sc-23950, 1/1,000), and anti-&#x003b1;-tubulin Ab (sc-5286, 1/1,000) were purchased from Santa Cruz Biotechnology, Inc. Anti-PARP Ab (#9542S, 1/1,000), anti-caspase3 Ab (#9665S, 1/1,000), anti-phospho-p53 Ab (#9286, 1/1,000), anti-p21 Ab (#2947S, 1/1,000), anti-phospho-ATR Ab (#9947, 1/1,000), anti-ATR Ab (#2790, 1/1,000), anti-phospho-Chk1 (Ser345) Ab (#2348, 1/1,000), anti-Chk1 Ab (#2360, 1/1,000), anti-phospho-Chk2 (Thr68) Ab (#2197, 1/1,000), anti-Chk2 Ab (#3440, 1/1,000), anti-phospho-Cdc2 (Tyr15) Ab (#4539, 1/1,000), anti-Cdc2 Ab (#9116, 1/1,000), anti-H2A.X Ab (#7631, 1/1,000), and anti-phospho-histone H2A.X (Ser139) Ab (#9718, 1/1,000) were purchased from Cell Signaling Technology, Inc.</p></div><div id="sec-a.k.b.j" class="sec"><h3 id="sec-a.k.b.jtitle">Assessment of mitotic catastrophes</h3><p class="p p-first-last">CAL27/H2B-mCherry/AcGFP-&#x003b1;-tubulin cells were seeded on collagen-coated glass-bottom dishes (CELLview #627870, Greiner). The next day, the cells were treated with control medium, Adv, RCS, or Adv + RCS, and time-lapse images were obtained every 10 min using a confocal microscope LSM 700 equipped with CO<sub>2</sub>, temperature, and humidity controller (Carl Zeiss) or fluorescent microscope BZ-X800 equipped with a time-lapse module (BZ-H4XT) (KEYENCE). The cells were maintained at 37&#x000b0;C and 5% CO<sub>2</sub>, under humidified conditions. Time-lapse images from fluorescent microscopy were used to analyze the cell fate.</p></div><div id="sec-a.k.b.k" class="sec sec-last"><h3 id="sec-a.k.b.ktitle">Statistical analysis</h3><p class="p p-first-last">All quantitative data are expressed as mean &#x000b1; standard deviation (SD). Statistical analyses for cell death inhibition with z-VAD-fmk treatment, and cell death in combination with Adv treatment and HDAC6 KD were performed using two-way ANOVA followed by Bonferroni's multiple comparison test. For the analysis of the M-phase duration, the Kruskal-Wallis test followed by Dunn's multiple comparison test was used. Statistical significance was set at P&#x0003c;0.05. All analyses were performed using GraphPad Prism 5 software (GraphPad Software, Inc.). The synergistic effect was assessed as follows. Based on nesting all elapsed hours for each experiment, mixed-effect linear regression analyses were performed by setting the number of cell deaths as the dependent variables and the concentration of the two anticancer drugs as independent variables. To assess the possible synergistic effects of the two drugs, the interaction term was added as one of the independent variables in the model to calculate p-for-interaction. All statistical analyses were performed using Stata version 17.0 (Stata Corp.). When the mono treatment was enough to kill almost all cells, the analysis indicated an 'antagonistic effect', because the dead cell count in the combination treatment group was smaller than the dead cell count in each mono treatment group.</p></div></div><div id="sec-a.k.c" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.k.ctitle">Results</h2><div id="sec-a.k.c.b" class="sec sec-first"><h3 id="sec-a.k.c.btitle">Combined treatment of Adv and RCS synergistically induces cell death in TP53-mutated HNSCC cells</h3><p class="p p-first-last">To assess the effect of the combined treatment of Adv and RCS on <em>TP53</em>-mutated HNSCC cells, namely CAL27, HSC-3, SAS, Detroit562, and OSC-19 cells, and HPV-positive UPCI-SCC-154 cells, which showed impaired p53, these cells were treated with Adv and RCS for 48 h and PI-positive dead cell number was measured using a live cell imaging system. In HNSCC cells, treatment with Adv and/or RCS induced cell death in a dose- and time-dependent manner. Notably, co-administration of Adv and RCS synergistically enhanced cell death in four out of five <em>TP53</em>-mutated HNSCC cell lines (except Detroit562 cells) as well as in the HPV-positive UPCI-SCC-154 cell line (<a href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344" co-legend-rid="lgnd_f1-ijo-60-05-05344"><span>Figs. 1</span></a> and <a href="#SD1-IJO-60-05-05344" rid="SD1-IJO-60-05-05344" class=" supplementary-material">S1</a>). To address whether this synergistic effect was ubiquitous, breast cancer cell lines (MDA-MB-231 and MCF7) and a lung cancer cell line (A549) were also treated with Adv and/or RCS for 48 h (<a href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344" co-legend-rid="lgnd_f1-ijo-60-05-05344"><span>Figs. 1</span></a> and <a href="#SD1-IJO-60-05-05344" rid="SD1-IJO-60-05-05344" class=" supplementary-material">S1</a>). Although co-administration of RCS with Adv led to enhanced cell death in MDA-MB-231 cells with <em>TP53</em> mutation, little or no enhanced cell death was observed in MCF7 and A549 cells, both carrying wild-type <em>TP53</em>. Because Adv has been reported to induce mitotic catastrophe in <em>TP53</em>-mutated cells, we hypothesized that RCS enhanced Adv-induced mitotic catastrophe in <em>TP53</em>-mutated cells but not in wild-type <em>TP53</em> cells. To address this issue, we next compared the induction of cell death between <em>TP53</em> wild-type and <em>TP53</em> knockout (KO) A549 cells, which were established using the CRISPR-Cas9 system (<a href="/pmc/articles/PMC8997343/figure/f2-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-60-05-05344" rid-ob="ob-f2-ijo-60-05-05344" co-legend-rid="lgnd_f2-ijo-60-05-05344"><span>Fig. 2A</span></a>). Although TP53-KO A549 cells did not show altered sensitivity to Adv as compared to wild-type A549 cells, co-administration of RCS significantly enhanced cell death in TP53-KO but not TP53-WT A549 cells (<a href="/pmc/articles/PMC8997343/figure/f2-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-60-05-05344" rid-ob="ob-f2-ijo-60-05-05344" co-legend-rid="lgnd_f2-ijo-60-05-05344"><span>Fig. 2B</span></a>). To further confirm this observation, we established TP53-KO MCF7 cells using the CRISPR-Cas9 system (<a href="#SD1-IJO-60-05-05344" rid="SD1-IJO-60-05-05344" class=" supplementary-material">Fig. S2A</a>). Although wild-type MCF7 cells showed slight synergistic cell death in the combined treatment of Adv and RCS, TP53-KO MCF7 cells showed increased synergistic cell death by the combined treatment as shown in A549 cells (<a href="#SD1-IJO-60-05-05344" rid="SD1-IJO-60-05-05344" class=" supplementary-material">Fig. S2B</a>). This indicated that the combination treatment of Adv and RCS can synergistically induce cell death in cells lacking p53 function.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f1-ijo-60-05-05344" co-legend-rid="lgnd_f1-ijo-60-05-05344"><a href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140625581199200"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8997343_IJO-60-05-05344-g00.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-60-05-05344-g00.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8997343/bin/IJO-60-05-05344-g00.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140625581199200"><a target="object" rel="noopener" href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f1-ijo-60-05-05344"><div><a class="figpopup" href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344">Figure 1</a></div><!--caption a7--><div class="caption"><p>Ricolinostat enhances adavosertib-induced cytotoxicity in HNSCC cell lines. CAL27, UPCI-SCC-154, HSC-3, SAS, MDA-MB-231, and A549 cells were treated with Adv in combination with RCS for up to 48 h. Cells were monitored using IncuCyte live cell imaging system, and dead cell number was assessed using PI staining. Time-dependent and dose-dependent cell death numbers are shown in the left and the middle panels, respectively. Representative data of three independent experiments are shown. n=3, bar, mean &#x000b1; SD. Synergistically enhanced cell death in the combination treatment was analyzed as described in Materials and methods and summarized in the right panels. A significant synergistic effect with both Adv and RCS treatment with P&#x0003c;0.05 is shown in red. An antagonistic effect with P&#x0003c;0.05 is shown in blue. HNSCC, head and neck squamous cell carcinoma; Adv, adavosertib; RCS, ricolinostat.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f2-ijo-60-05-05344" co-legend-rid="lgnd_f2-ijo-60-05-05344"><a href="/pmc/articles/PMC8997343/figure/f2-ijo-60-05-05344/" target="figure" rid-figpopup="f2-ijo-60-05-05344" rid-ob="ob-f2-ijo-60-05-05344"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140625571237568"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8997343_IJO-60-05-05344-g01.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-60-05-05344-g01.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8997343/bin/IJO-60-05-05344-g01.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140625571237568"><a target="object" rel="noopener" href="/pmc/articles/PMC8997343/figure/f2-ijo-60-05-05344/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f2-ijo-60-05-05344"><div><a class="figpopup" href="/pmc/articles/PMC8997343/figure/f2-ijo-60-05-05344/" target="figure" rid-figpopup="f2-ijo-60-05-05344" rid-ob="ob-f2-ijo-60-05-05344">Figure 2</a></div><!--caption a7--><div class="caption"><p>Combined treatment of adavosertib and ricolinostat enhances cell death only in TP53-KO A549 cells. (A) TP53 KO in A549 cells was confirmed by western blotting. Expression of p53, phospho-p53, and p21 was assessed after doxorubicin (DOX) (1 <em>&#x000b5;</em>M) treatment for 24 h. &#x003b2;-actin was used as a loading control. Relative band intensity of p-p53/p53 was calculated and is summarized in the right panel. (B) TP53-WT and TP53-KO A549 cells were treated with Adv in combination with RCS for up to 48 h. Cells were monitored using IncuCyte live cell imaging system, and dead cell number was assessed by PI staining. Dose-dependent and time-dependent cell death numbers are shown. The synergistic effect on cell death in combination treatment was assessed and is summarized at the right. Representative data of three independent experiments are shown. n=3, bar, mean &#x000b1; SD. Adv, adavosertib; RCS, ricolinostat.</p></div></div></div></div><div id="sec-a.k.c.c" class="sec"><h3 id="sec-a.k.c.ctitle">Combined treatment of Adv and RCS in cancer cells leads to mitotic catastrophe</h3><p class="p p-first-last">To identify the mechanism by which the combined treatment of Adv and RCS leads to enhanced cell death, we treated CAL27 cells with Adv and RCS for 24 h and observed their cell morphology. In response to drug treatment, CAL27 cells showed nuclear fragmentation and chromatin condensation (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3A</span></a>), which are characteristic features of cells undergoing apoptosis. Western blotting revealed that Adv or RCS treatment induced the cleavage of caspase-3, and co-administration of the two drugs further increased the cleavage of caspase-3 in CAL 27 cells (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3B</span></a>). Additionally, Adv-and RCS-induced cell death was abolished in the presence of a pan-caspase inhibitor, z-VAD-fmk (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3C</span></a>). These data demonstrated that co-administration of Adv and RCS induced apoptosis. Adv is known to induce mitotic catastrophe, which subsequently leads to apoptotic or non-apoptotic cell death (<a href="#b31-ijo-60-05-05344" rid="b31-ijo-60-05-05344" class=" bibr popnode">31</a>). To investigate whether the co-administration of Adv and RCS enhanced mitotic catastrophe, we established CAL27 cells stably expressing AcGFP-&#x003b1;-tubulin and histone-H2B-mCherry to monitor mitosis. Time-lapse imaging showed that most cells treated with Adv could not complete mitosis and underwent cell death, which indicated mitotic catastrophe (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3D-F</span></a>). Additionally, Adv treatment resulted in a prolonged duration of mitosis (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3G</span></a>). On the contrary, although RCS treatment induced cell death, most of the cell death occurred during interphase, and most RCS-treated cells did not enter metaphase (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3E and F</span></a>). This indicated that, unlike Adv, RCS hardly induced mitotic catastrophe. Of note, when CAL27 cells were simultaneously exposed to Adv and RCS, dead cell counts were increased and most of the cell death occurred during mitosis (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3D-F</span></a>). However, the duration of the mitotic phase until cell death was not further extended as compared to the cells treated with Adv alone (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3G</span></a>). These data showed that RCS enhanced the Adv-induced mitotic catastrophe.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140625571208592"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8997343_IJO-60-05-05344-g02.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-60-05-05344-g02.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8997343/bin/IJO-60-05-05344-g02.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140625571208592"><a target="object" rel="noopener" href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f3-ijo-60-05-05344"><div><a class="figpopup" href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344">Figure 3</a></div><!--caption a7--><div class="caption"><p>Co-administration of ricolinostat enhances adavosertib-induced mitotic catastrophe in CAL27 cells. (A) CAL27 cells were treated with control, Adv (0.5 <em>&#x000b5;</em>M), RCS (5 <em>&#x000b5;</em>M), or Adv+RCS for 24 h and then stained with May-Gr&#x000fc;nwald-Giemsa stain. Scale bar, 25 <em>&#x000b5;</em>m. Arrowheads indicate nuclear chromatin condensation. (B) CAL27 cells were treated with control, Adv (0.5 <em>&#x000b5;</em>M), RCS (5 <em>&#x000b5;</em>M), and Adv + RCS for 24 h, and then, cleavage of PARP and caspase-3 were assessed by western blotting. (C) CAL27 cells were treated with control, Adv (0.5 <em>&#x000b5;</em>M), RCS (5 <em>&#x000b5;</em>M), or Adv + RCS in the presence of z-VAD-fmk (0, 25, and 50 <em>&#x000b5;</em>M) for 24 h, and dead cell number was monitored using IncuCyte live cell imaging system by PI staining. n=7, bar, mean &#x000b1; SD; <sup>*</sup>P&#x0003c;0.05 vs. 0 <em>&#x000b5;</em>M z-VAD-fmk. (D) Live cell imaging of CAL27 cells expressing AcGFP-&#x003b1;-tubulin and Histone H2B-mCherry. Cells were treated with control, Adv (0.5 <em>&#x000b5;</em>M), or Adv + RCS (5 <em>&#x000b5;</em>M) and monitored using confocal microscopy. Representative images of cells after the nuclear envelope breakdown (NEBD) are shown. Time after the NEBD is shown in the upper right corner of each image. Scale bar, 20 <em>&#x000b5;</em>m. (E) Five representative cell fates in each treated cell with control, Adv (0.5 <em>&#x000b5;</em>M), RCS (5 <em>&#x000b5;</em>M), or Adv + RCS are shown in a tree diagram. (F) The ratio of cell death in mitosis or interphase in each treated cell is summarized in the pie chart. n for each condition is shown at the bottom. Data from three independent experiments are summarized. (G) Time from NEBD to telophase or cell death was assessed and summarized. n=75, 59, 29, 46. Data from three independent experiments are summarized. <sup>*</sup>P&#x0003c;0.05 vs. the control. PARP, poly(ADP-ribose) polymerase; Adv, adavosertib; RCS, ricolinostat.</p></div></div></div></div><div id="sec-a.k.c.d" class="sec"><h3 id="sec-a.k.c.dtitle">RCS promotes Adv-induced mitotic entry along with the increment of &#x003b3;-H2A.X expression</h3><p class="p p-first">Next, to address how RCS enhances Adv-induced mitotic catastrophe, we assessed the G2/M checkpoint and DNA damage response (DDR)-related proteins by western blotting in CAL27 cells (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Fig. 4A</span></a>). WEE1, a Ser/Thr protein kinase family member, phosphorylates CDK1 at Tyr15, inhibits its activity, and acts as a negative regulator for entry into mitosis (G2 to M transition) (<a href="#b32-ijo-60-05-05344" rid="b32-ijo-60-05-05344" class=" bibr popnode">32</a>). Thus, Adv treatment decreased CDK1 (Tyr15) phosphorylation (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Fig. 4A</span></a>). This indicated that CDK1 was activated, leading to premature mitotic entry. At the same time, we observed increased phosphorylation of Chk1 (Ser345), which indirectly inactivates CDK1. This increased p-Chk1 presumably compensated for the increased CDK1 activity. In contrast, RCS treatment suppressed Chk1 phosphorylation. Thus, co-administration of RCS with Adv suppressed p-Chk1 and p-CDK1. This appeared to further promote forced mitotic entry to induce mitotic catastrophe. In support of these findings, co-administration of the two drugs resulted in further increase in &#x003b3;-H2A.X expression, a marker of DNA double-strand breaks. These data suggest that RCS enhanced Adv-induced mitotic catastrophe by suppressing p-Chk1 and p-CDK1 (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Fig. 4A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140625571203648"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8997343_IJO-60-05-05344-g03.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-60-05-05344-g03.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8997343/bin/IJO-60-05-05344-g03.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140625571203648"><a target="object" rel="noopener" href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f4-ijo-60-05-05344"><div><a class="figpopup" href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344">Figure 4</a></div><!--caption a7--><div class="caption"><p>Ricolinostat suppresses phosphorylation of Chk1 and further suppresses p-CDK1 when co-administered with adavosertib. (A) CAL27 cells and (B) TP53-WT and TP53-KO A549 cells were treated with Adv (0.5 <em>&#x000b5;</em>M), RCS (5 <em>&#x000b5;</em>M), and Adv+RCS for 24 h (CAL27 cells) or 48 h (A549 cells), and then the expression of DNA damage response-related proteins (p-Chk2, Chk2, p-ATR, ATR, p-Chk1, Chk1, p-CDK1, CDK1, and &#x003b3;-H2A.X) was assessed by western blotting. To assess the inhibitory effect of HDAC6 by RCS, the level of acetylated (ac)-&#x003b1;-tubulin was monitored. Expression of &#x003b2;-actin was assessed as the loading control. The relative band intensity of each phosphorylated protein was calculated and summarized at the right. Representative data of three independent experiments are shown. Adv, adavosertib; RCS, ricolinostat; WT, wild-type; Chk, checkpoint kinase; ATR, ATR serine/threonine kinase; CDK1, cyclin-dependent kinase 1.</p></div></div></div><p class="p p-last">As shown in <a href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344" co-legend-rid="lgnd_f1-ijo-60-05-05344"><span>Fig. 1</span></a>, the pronounced cell death induction by combined treatment of Adv and RCS appeared to be dependent on <em>TP53</em> mutations. We examined whether the co-administration of RCS suppressed p-Chk1 in both WT and TP53-KO A549 cells (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Fig. 4B</span></a>). In both cells, Adv treatment increased p-Chk1 and suppressed p-CDK1, similar to that observed in CAL27 cells. Although co-administration of RCS with Adv suppressed p-CDK1 and p-Chk1 in both cell lines, &#x003b3;-H2A.X expression was increased only in TP53-KO A549 cells. This may reflect the dependency of <em>TP53</em>-mutated cells on the G2/M checkpoint. These data also suggest that RCS enhances premature mitotic entry by suppressing p-Chk1 in A549 cells. Additionally, we assessed the DDR-related protein expression in Detroit562 cells which carry mutated-<em>TP53</em> but did not show pronounced cell death by combined treatment of Adv and RCS. Detroit562 cells showed almost the same result as WT A549 cells and failed to further upregulate &#x003b3;-H2A.X expression as compared to treatment with Adv alone (<a href="#SD1-IJO-60-05-05344" rid="SD1-IJO-60-05-05344" class=" supplementary-material">Fig. S3</a>). This suggests that some of the <em>TP53</em>-mutated cell lines may have gained a compensatory mechanism to p53 and are insensitive to co-administration of RCS with Adv.</p></div><div id="sec-a.k.c.e" class="sec sec-last"><h3 id="sec-a.k.c.etitle">RCS enhanced cell death induction via inhibition of HDAC6</h3><p class="p p-first-last">It has been reported that although RCS selectively inhibits HDAC6 (IC<sub>50</sub>=4.7 nM), it also inhibits HDAC1, 2, and 3 (IC<sub>50</sub>=58, 48, and 51 nM, respectively) at higher concentrations (<a href="#b33-ijo-60-05-05344" rid="b33-ijo-60-05-05344" class=" bibr popnode">33</a>). To clarify whether the enhanced cell death mediated by RCS was due to the inhibition of HDAC6, we knocked down HDAC6 using three different siRNAs (siHDAC6 #2, #3, and #4). All three siRNAs efficiently knocked down HDAC6 and increased acetylated &#x003b1;-tubulin, which is a substrate for HDAC6 (<a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><span>Fig. 5A</span></a>). Although KD of HDAC6 by itself did not change p-Chk1 levels or &#x003b3;-H2A.X expression levels, Adv treatment in HDAC6-KD cells resulted in increased &#x003b3;-H2A.X expression, as in the case of CAL27 cells treated with RCS and Adv (<a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><span>Fig. 5B</span></a>). However, we did not observe the suppression of p-Chk1 or p-CDK1 in Adv-treated HDAC6-KD cells. In terms of cell death induction, treatment with Adv in HDAC6-KD cells significantly and synergistically increased cell death, as in the case of CAL27 cells concomitantly treated with RCS and Adv (<a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><span>Fig. 5C-E</span></a>). This suggested that increased DNA damage and enhanced cell death by co-administration of RCS with Adv appeared to have been caused by HDAC6 inhibition, but the enhanced mitotic catastrophe caused by RCS addition to Adv treatment may be independent of HDAC6 inhibition.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140625578736800"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8997343_IJO-60-05-05344-g04.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-60-05-05344-g04.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8997343/bin/IJO-60-05-05344-g04.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140625578736800"><a target="object" rel="noopener" href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f5-ijo-60-05-05344"><div><a class="figpopup" href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344">Figure 5</a></div><!--caption a7--><div class="caption"><p>HDAC6 knockdown (KD) enhances adavosertib-induced cell death in CAL27 cells. (A) Knockdown efficiency of HDAC6 in CAL27 cells with three different HDAC6 siRNAs was assessed by western blotting. (B) CAL27 cells were transfected with siLuc or three different siHDAC6 siRNAs (<sup>#</sup>2-4) and then treated with or without Adv (1 <em>&#x000b5;</em>M) for 24 h. Expression of DDR-related proteins was detected by western blotting. Expression of HDAC6 and acetylated (ac)-&#x003b1;-tubulin were monitored to assess the KD efficiency. Representative data of three independent experiments are shown. (C and D) CAL27 cells were transfected with siLuc or three different siHDAC6 siRNAs (#2-4) and then treated with various concentrations of Adv up to 24 h. Cells were monitored using IncuCyte live cell imaging system, and dead cell number was assessed using PI staining. Dose-dependent (C) and time-dependent (D) cell death numbers are shown. Representative data of three independent experiments are shown. n=3, bar, mean &#x000b1; SD. <sup>*</sup>P&#x0003c;0.05 vs. siLuc. (E) The synergistic effect of cell death in the combination of Adv treatment and HDAC6 KD shown in (C) and (D) was assessed and is summarized. Adv, adavosertib; RCS, ricolinostat; HDAC6, histone deacetylase 6; DDR, DNA damage response.</p></div></div></div></div></div><div id="sec-a.k.d" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.k.dtitle">Discussion</h2><p class="p p-first">In the present study, the combined WEE1 G2 checkpoint kinase (WEE1) inhibitor adavosertib (Adv) and the histone deacetylase 6 (HDAC6)-selective inhibitor ricolinostat (RCS) treatment exhibited synergistic cytotoxicity in <em>TP53</em>-mutated, impaired p53 function by HPV-infection, or TP53-KO HNSCC, lung cancer, and breast cancer cell lines likely via enhanced induction of Adv-induced mitotic catastrophe (<a href="/pmc/articles/PMC8997343/figure/f6-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6-ijo-60-05-05344" rid-ob="ob-f6-ijo-60-05-05344" co-legend-rid="lgnd_f6-ijo-60-05-05344"><span>Fig. 6</span></a>). WEE1 phosphorylates the amino acids Tyr15 and Thr14 of CDK1, which keeps the kinase activity of CDK1 low and prevents entry into mitosis (<a href="#b32-ijo-60-05-05344" rid="b32-ijo-60-05-05344" class=" bibr popnode">32</a>). As p53 regulates the G1/S checkpoint, <em>TP53</em>-mutated cells rely on the G2/M checkpoint to arrest the cell cycle to repair their DNA damage. Thus, <em>TP53</em>-mutated cells with increased replication stress appeared to exhibit greater sensitivity to WEE1 inhibitors (<a href="#b34-ijo-60-05-05344" rid="b34-ijo-60-05-05344" class=" bibr popnode">34</a>,<a href="#b35-ijo-60-05-05344" rid="b35-ijo-60-05-05344" class=" bibr popnode">35</a>). The synergistic effect of the two-drug combination shown in <a href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344" co-legend-rid="lgnd_f1-ijo-60-05-05344"><span>Fig. 1</span></a> appeared to be mediated through forced entry of the cell into M phase by CDK1 activation. Indeed, the two-drug combination resulted in enhanced dephosphorylation of CDK1, which is an active state of CDK1, as compared to that in the treatment of Adv alone. This was accompanied by pronounced &#x003b3;-H2A.X expression, which indicated an increase in DNA double-strand breaks in <em>TP53</em>-mutated cells (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Fig. 4A and B</span></a>). In Adv-treated cells, a compensatory mechanism appeared to be induced, leading to an increased expression of p-Chk1. However, combination treatment with RCS suppressed p-Chk1 upregulation and further activated CDK1 to promote premature mitotic entry (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Figs. 4</span></a> and <a href="/pmc/articles/PMC8997343/figure/f6-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6-ijo-60-05-05344" rid-ob="ob-f6-ijo-60-05-05344" co-legend-rid="lgnd_f6-ijo-60-05-05344"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and6</span></span><span>6</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f6-ijo-60-05-05344" co-legend-rid="lgnd_f6-ijo-60-05-05344"><a href="/pmc/articles/PMC8997343/figure/f6-ijo-60-05-05344/" target="figure" rid-figpopup="f6-ijo-60-05-05344" rid-ob="ob-f6-ijo-60-05-05344"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140625578732896"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8997343_IJO-60-05-05344-g05.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-60-05-05344-g05.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8997343/bin/IJO-60-05-05344-g05.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140625578732896"><a target="object" rel="noopener" href="/pmc/articles/PMC8997343/figure/f6-ijo-60-05-05344/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f6-ijo-60-05-05344"><div><a class="figpopup" href="/pmc/articles/PMC8997343/figure/f6-ijo-60-05-05344/" target="figure" rid-figpopup="f6-ijo-60-05-05344" rid-ob="ob-f6-ijo-60-05-05344">Figure 6</a></div><!--caption a7--><div class="caption"><p>Schema of the effect of adavosertib and ricolinostat on the G2/M checkpoint. In <em>TP53</em>-mutated cells, DNA repair is dependent on the G2/M checkpoint regulated by CDK1. CDK1 is a key regulator inducing cell cycle progression through the G2/M checkpoint. WEE1 phosphorylates and inhibits CDK1. Adavosertib inhibits WEE1 and then CDK1 is dephosphorylated and activated. Chk1 inhibits Cdc25, which dephosphorylates and activates CDK1. Ricolinostat decreases the phosphorylation of Chk1, indicating inhibition of Chk1. Chk, checkpoint kinase; ATR, ATR serine/threonine kinase; ATM, ATM serine/threonine kinase; CDK1, cyclin-dependent kinase 1; HDAC6, histone deacetylase 6; WEE1, WEE1 G2 checkpoint kinase.</p></div></div></div><p>Adv is an orally available, first-in-class, reversible WEE1 inhibitor (<a href="#b36-ijo-60-05-05344" rid="b36-ijo-60-05-05344" class=" bibr popnode">36</a>). Most clinical trials using WEE1 inhibitors have been conducted as a combination with chemotherapy or radiotherapy (<a href="#b37-ijo-60-05-05344" rid="b37-ijo-60-05-05344" class=" bibr popnode">37</a>-<a href="#b40-ijo-60-05-05344" rid="b40-ijo-60-05-05344" class=" bibr popnode">40</a>). In the case of WEE1 inhibitor monotherapy against recurrent uterine serous carcinoma, which frequently possesses <em>TP53</em> mutation, the treatment showed significant elongation of progression-free survival (PFS) and a high response rate (<a href="#b41-ijo-60-05-05344" rid="b41-ijo-60-05-05344" class=" bibr popnode">41</a>). Consistent with our results (<a href="/pmc/articles/PMC8997343/figure/f1-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-ijo-60-05-05344" rid-ob="ob-f1-ijo-60-05-05344" co-legend-rid="lgnd_f1-ijo-60-05-05344"><span>Figs. 1</span></a> and <a href="/pmc/articles/PMC8997343/figure/f2-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-60-05-05344" rid-ob="ob-f2-ijo-60-05-05344" co-legend-rid="lgnd_f2-ijo-60-05-05344"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and2),</span></span><span>2</span></a>), several previous studies have reported that sensitivity to Adv is dependent on <em>TP53</em> mutation status (<a href="#b6-ijo-60-05-05344" rid="b6-ijo-60-05-05344" class=" bibr popnode">6</a>,<a href="#b7-ijo-60-05-05344" rid="b7-ijo-60-05-05344" class=" bibr popnode">7</a>,<a href="#b42-ijo-60-05-05344" rid="b42-ijo-60-05-05344" class=" bibr popnode">42</a>), whereas a few other reports have shown that <em>TP53</em> status does not alter sensitivity to Adv (<a href="#b43-ijo-60-05-05344" rid="b43-ijo-60-05-05344" class=" bibr popnode">43</a>). This may suggest that <em>TP53</em> single gene mutation by itself is not sufficient to determine sensitivity to WEE1 inhibitor monotherapy.</p><p>HDAC6 is a unique member of the HDAC subfamily possessing two catalytic domains, namely DAC1 with E3-ligase activity and DAC2 with deacetylase activity (<a href="#b44-ijo-60-05-05344" rid="b44-ijo-60-05-05344" class=" bibr popnode">44</a>). HDAC6 deacetylates histones; however, cytoplasmic proteins, namely &#x003b1;-tubulin, cortactin, and heat shock protein 90 (HSP90), are also deacetylated by HDAC6 (<a href="#b45-ijo-60-05-05344" rid="b45-ijo-60-05-05344" class=" bibr popnode">45</a>-<a href="#b47-ijo-60-05-05344" rid="b47-ijo-60-05-05344" class=" bibr popnode">47</a>). The roles of HDAC6 in tumorigenesis and cell-cycle progression have been reported (<a href="#b23-ijo-60-05-05344" rid="b23-ijo-60-05-05344" class=" bibr popnode">23</a>,<a href="#b48-ijo-60-05-05344" rid="b48-ijo-60-05-05344" class=" bibr popnode">48</a>,<a href="#b49-ijo-60-05-05344" rid="b49-ijo-60-05-05344" class=" bibr popnode">49</a>). The overexpression of HDAC6 has been reported in acute myeloid leukemia, oral squamous cell carcinoma, and ovarian cancer (<a href="#b50-ijo-60-05-05344" rid="b50-ijo-60-05-05344" class=" bibr popnode">50</a>-<a href="#b52-ijo-60-05-05344" rid="b52-ijo-60-05-05344" class=" bibr popnode">52</a>), and higher HDAC6 expression appears to correlate with tumor progression and malignancy in hepatocellular carcinoma and esophageal squamous cell carcinoma (<a href="#b53-ijo-60-05-05344" rid="b53-ijo-60-05-05344" class=" bibr popnode">53</a>,<a href="#b54-ijo-60-05-05344" rid="b54-ijo-60-05-05344" class=" bibr popnode">54</a>). In our study, HDAC6 inhibition by RCS suppressed cell cycle progression (<a href="/pmc/articles/PMC8997343/figure/f3-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-60-05-05344" rid-ob="ob-f3-ijo-60-05-05344" co-legend-rid="lgnd_f3-ijo-60-05-05344"><span>Fig. 3</span></a>), which was consistent with previous reports showing that RCS or other HDAC inhibitors caused G2/M phase arrest (<a href="#b53-ijo-60-05-05344" rid="b53-ijo-60-05-05344" class=" bibr popnode">53</a>,<a href="#b55-ijo-60-05-05344" rid="b55-ijo-60-05-05344" class=" bibr popnode">55</a>). In contrast, in the presence of Adv + RCS, the cells underwent a pronounced mitotic catastrophe, indicating increased entry into the M-phase. The molecular mechanisms underlying this contradictory phenomenon remain unclear.</p><p>Our study demonstrated that HDAC6 inhibition by RCS suppressed p-Chk1 expression (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Fig. 4A and B</span></a>), whereas HDAC6 KD slightly increased Chk1 (<a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><span>Fig. 5B</span></a>). Thus, suppression of p-Chk1 by RCS seemed to be HDAC6-independent. However, as described above, in addition to deacetylase activity, HDAC6 possesses E3-ligase activity, which ubiquitinates and degrades Chk1 and functions in DDR. Therefore, it was reported that HDAC6 deletion resulted in an increase in Chk1, which enhanced radiation-induced cell cycle arrest in non-small cell lung cancer cells (<a href="#b44-ijo-60-05-05344" rid="b44-ijo-60-05-05344" class=" bibr popnode">44</a>). In our system, although HDAC6 KD suppressed both activities, RCS interacted only with DAC2 and E3-ligase activity localized in DAC1 appeared to be intact. If the increase in Chk1 due to DAC1 inhibition overcomes the inhibition of p-Chk1 caused by DAC2 inhibition, the HDAC6 KD experiment alone is not sufficient to determine whether RCS suppresses p-Chk1 via HDAC6. To address this, we need to further evaluate the specific disruption/deletion of the DAC2 domain in HDAC6.</p><p>In terms of the Chk1-CDK1 axis, Adv treatment of HDAC6-KD cells resulted in increased &#x003b3;-H2A.X and cell death despite no decrease in p-Chk1 or p-CDK1 (<a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><span>Fig. 5</span></a>). This indicates that the enhanced cell death by siHDAC6 or RCS is not limited to be mediated by Chk1-CDK1. As previously reported, we also showed that RCS treatment and HDAC6 KD resulted in &#x003b1;-tubulin acetylation (<a href="/pmc/articles/PMC8997343/figure/f4-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-60-05-05344" rid-ob="ob-f4-ijo-60-05-05344" co-legend-rid="lgnd_f4-ijo-60-05-05344"><span>Figs. 4</span></a> and <a href="/pmc/articles/PMC8997343/figure/f5-ijo-60-05-05344/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-60-05-05344" rid-ob="ob-f5-ijo-60-05-05344" co-legend-rid="lgnd_f5-ijo-60-05-05344"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and5)</span></span><span>5</span></a>) (<a href="#b45-ijo-60-05-05344" rid="b45-ijo-60-05-05344" class=" bibr popnode">45</a>). It is well-known that post-translational modifications of tubulins contribute to microtubule dynamics, which are crucial for proper spindle organization and cell cycle progression (<a href="#b56-ijo-60-05-05344" rid="b56-ijo-60-05-05344" class=" bibr popnode">56</a>). CYLD, a tumor suppressor gene product, has been reported to bind and inactivate HDAC6 along with increased acetylation of tubulin, which negatively regulates cell-cycle progression (<a href="#b23-ijo-60-05-05344" rid="b23-ijo-60-05-05344" class=" bibr popnode">23</a>). In addition, tubastatin A, an HDAC6 inhibitor, has been reported to disrupt maturational progression and meiotic apparatus assembly in mouse oocytes (<a href="#b57-ijo-60-05-05344" rid="b57-ijo-60-05-05344" class=" bibr popnode">57</a>). Therefore, it is still possible that HDAC6 inhibitors including RCS cause abnormal mitosis by constitutively enhancing the acetylation of tubulins, leading to disruption of microtubule dynamics. This may also play a role in promoting the Adv-induced mitotic catastrophe.</p><p class="p p-last">To the best of our knowledge, this is the first report showing that RCS with a higher selectivity against HDAC6 suppresses p-Chk1. Although suppression of p-Chk1 by RCS may be independent of HDAC6, enhanced DNA damage and cell death were observed in both RCS-treated and HDAC6-KD cells in combination with Adv treatment. As prominent cell death in Adv + RCS-treated cells was only observed in <em>TP53</em>-mutated and TP53-KO cells, this drug combination appears to be much less toxic to normal cells with intact <em>TP53</em> than in <em>TP53</em>-mutated cancer cells. Applying this drug combination in the experiment with the tumor xenograft model appears to have potential for future research. Although <em>in vivo</em> studies remain to be carried out, this drug combination with high specificity for cells lacking p53 function could be a good candidate for the treatment of HNSCC patients carrying <em>TP53</em> mutations as well as human papillomavirus (HPV)-positive HNSCC patients lacking p53 function.</p></div><div id="sec-a.k.e" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.k.etitle">Supplementary Data</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1-IJO-60-05-05344"><div class="sup-box half_rhythm" id="d64e617"><a href="/pmc/articles/PMC8997343/bin/Supplementary_Data.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(625K, pdf)</sup></div></div></div><div id="ack-a.l.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.l.atitle">Acknowledgments</h2><div class="sec"><p>Not applicable.</p></div></div><div id="funding-group-a.j.b.u" class="tsec sec"><h2 class="head no_bottom_margin" id="funding-group-a.j.b.utitle">Funding Statement</h2><p>This study was supported by JSPS KAKENHI Grant Number 20K07298 (to NT) and the Cancer Research Grant afforded by the Tokyo Medical University Cancer Research Foundation (to KM).</p></div><div id="sec-a.l.b" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.l.btitle">Availability of data and materials</h2><!--/article/back/sec/--><p class="p p-first-last">The datasets used during the present study are available from the corresponding authors upon reasonable request.</p></div><div id="sec-a.l.c" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.l.ctitle">Authors' contributions</h2><!--/article/back/sec/--><p class="p p-first-last">KM (Miyazawa) and NT conceived and designed the present study. KM (Miyake), NT and HK (Kazama) performed the experiments. KM (Miyake), NT and HK (Kikuchi) analyzed, interpretated the data. KM (Miyake), NT and KM (Miyazawa) confirmed the integrity of the data. KM (Miyazawa), NT, MH, KT and KM (Miyake) wrote, reviewed and/or revised the manuscript. All authors read and approved the manuscript and agree to be accountable for all aspects of the research in ensuring that the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p></div><div id="sec-a.l.d" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.l.dtitle">Ethics approval and consent to participate</h2><!--/article/back/sec/--><p class="p p-first-last">Not applicable.</p></div><div id="sec-a.l.e" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.l.etitle">Patient consent for publication</h2><!--/article/back/sec/--><p class="p p-first-last">Not applicable.</p></div><div id="sec-a.l.f" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="sec-a.l.ftitle">Competing interests</h2><!--/article/back/sec/--><p class="p p-first-last">The authors declare that they have no competing interests.</p></div><div id="ref-list-a.l.g" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.l.gtitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1-ijo-60-05-05344">1. <span class="element-citation">Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. <span><span class="ref-journal">CA Cancer J Clin. </span>2018;<span class="ref-vol">68</span>:394–424. doi: 10.3322/caac.21492.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30207593" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3322%2Fcaac.21492" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CA+Cancer+J+Clin&amp;title=Global+cancer+statistics+2018:+GLOBOCAN+estimates+of+incidence+and+mortality+worldwide+for+36+cancers+in+185+countries&amp;author=F+Bray&amp;author=J+Ferlay&amp;author=I+Soerjomataram&amp;author=RL+Siegel&amp;author=LA+Torre&amp;volume=68&amp;publication_year=2018&amp;pages=394-424&amp;pmid=30207593&amp;doi=10.3322/caac.21492&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2-ijo-60-05-05344">2. <span class="element-citation">Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. <span><span class="ref-journal">Science. </span>2011;<span class="ref-vol">333</span>:1154–1157. doi: 10.1126/science.1206923.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3162986/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21798897" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1206923" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Exome+sequencing+of+head+and+neck+squamous+cell+carcinoma+reveals+inactivating+mutations+in+NOTCH1&amp;author=N+Agrawal&amp;author=MJ+Frederick&amp;author=CR+Pickering&amp;author=C+Bettegowda&amp;author=K+Chang&amp;volume=333&amp;publication_year=2011&amp;pages=1154-1157&amp;pmid=21798897&amp;doi=10.1126/science.1206923&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3-ijo-60-05-05344">3. <span class="element-citation">Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al. The mutational landscape of head and neck squamous cell carcinoma. <span><span class="ref-journal">Science. </span>2011;<span class="ref-vol">333</span>:1157–1160. doi: 10.1126/science.1208130.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3415217/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21798893" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1126%2Fscience.1208130" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+mutational+landscape+of+head+and+neck+squamous+cell+carcinoma&amp;author=N+Stransky&amp;author=AM+Egloff&amp;author=AD+Tward&amp;author=AD+Kostic&amp;author=K+Cibulskis&amp;volume=333&amp;publication_year=2011&amp;pages=1157-1160&amp;pmid=21798893&amp;doi=10.1126/science.1208130&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4-ijo-60-05-05344">4. <span class="element-citation">Wang X, Sun Q. TP53 mutations, expression and interaction networks in human cancers. <span><span class="ref-journal">Oncotarget. </span>2017;<span class="ref-vol">8</span>:624–643. doi: 10.18632/oncotarget.13483.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5352183/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27880943" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.13483" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=TP53+mutations,+expression+and+interaction+networks+in+human+cancers&amp;author=X+Wang&amp;author=Q+Sun&amp;volume=8&amp;publication_year=2017&amp;pages=624-643&amp;pmid=27880943&amp;doi=10.18632/oncotarget.13483&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5-ijo-60-05-05344">5. <span class="element-citation">Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. <span><span class="ref-journal">Cell. </span>1990;<span class="ref-vol">63</span>:1129–1136. doi: 10.1016/0092-8674(90)90409-8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2175676" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0092-8674(90)90409-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The+E6+oncoprotein+encoded+by+human+papillomavirus+types+16+and+18+promotes+the+degradation+of+p53&amp;author=M+Scheffner&amp;author=BA+Werness&amp;author=JM+Huibregtse&amp;author=AJ+Levine&amp;author=PM+Howley&amp;volume=63&amp;publication_year=1990&amp;pages=1129-1136&amp;pmid=2175676&amp;doi=10.1016/0092-8674(90)90409-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6-ijo-60-05-05344">6. <span class="element-citation">Indovina P, Giordano A. Targeting the checkpoint kinase WEE1: Selective sensitization of cancer cells to DNA-damaging drugs. <span><span class="ref-journal">Cancer Biol Ther. </span>2010;<span class="ref-vol">9</span>:523–525. doi: 10.4161/cbt.9.7.11276.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20150761" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4161%2Fcbt.9.7.11276" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Targeting+the+checkpoint+kinase+WEE1:+Selective+sensitization+of+cancer+cells+to+DNA-damaging+drugs&amp;author=P+Indovina&amp;author=A+Giordano&amp;volume=9&amp;publication_year=2010&amp;pages=523-525&amp;pmid=20150761&amp;doi=10.4161/cbt.9.7.11276&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7-ijo-60-05-05344">7. <span class="element-citation">Hirai H, Arai T, Okada M, Nishibata T, Kobayashi M, Sakai N, Imagaki K, Ohtani J, Sakai T, Yoshizumi T, et al. MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. <span><span class="ref-journal">Cancer Biol Ther. </span>2010;<span class="ref-vol">9</span>:514–522. doi: 10.4161/cbt.9.7.11115.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20107315" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4161%2Fcbt.9.7.11115" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=MK-1775,+a+small+molecule+Wee1+inhibitor,+enhances+anti-tumor+efficacy+of+various+DNA-damaging+agents,+including+5-fluorouracil&amp;author=H+Hirai&amp;author=T+Arai&amp;author=M+Okada&amp;author=T+Nishibata&amp;author=M+Kobayashi&amp;volume=9&amp;publication_year=2010&amp;pages=514-522&amp;pmid=20107315&amp;doi=10.4161/cbt.9.7.11115&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8-ijo-60-05-05344">8. <span class="element-citation">Den Haese GJ, Walworth N, Carr AM, Gould KL. The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2. <span><span class="ref-journal">Mol Biol Cell. </span>1995;<span class="ref-vol">6</span>:371–385. doi: 10.1091/mbc.6.4.371.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC301198/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7626804" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1091%2Fmbc.6.4.371" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Cell&amp;title=The+Wee1+protein+kinase+regulates+T14+phosphorylation+of+fission+yeast+Cdc2&amp;author=GJ+Den+Haese&amp;author=N+Walworth&amp;author=AM+Carr&amp;author=KL+Gould&amp;volume=6&amp;publication_year=1995&amp;pages=371-385&amp;pmid=7626804&amp;doi=10.1091/mbc.6.4.371&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9-ijo-60-05-05344">9. <span class="element-citation">Sancar A, Lindsey-Boltz LA, Unsal-Ka&#x000e7;maz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. <span><span class="ref-journal">Annu Rev Biochem. </span>2004;<span class="ref-vol">73</span>:39–85. doi: 10.1146/annurev.biochem.73.011303.073723.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15189136" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev.biochem.73.011303.073723" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Biochem&amp;title=Molecular+mechanisms+of+mammalian+DNA+repair+and+the+DNA+damage+checkpoints&amp;author=A+Sancar&amp;author=LA+Lindsey-Boltz&amp;author=K+Unsal-Ka&#x000e7;maz&amp;author=S+Linn&amp;volume=73&amp;publication_year=2004&amp;pages=39-85&amp;pmid=15189136&amp;doi=10.1146/annurev.biochem.73.011303.073723&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10-ijo-60-05-05344">10. <span class="element-citation">Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: A molecular definition. <span><span class="ref-journal">Oncogene. </span>2004;<span class="ref-vol">23</span>:2825–2837. doi: 10.1038/sj.onc.1207528.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15077146" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.onc.1207528" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Cell+death+by+mitotic+catastrophe:+A+molecular+definition&amp;author=M+Castedo&amp;author=JL+Perfettini&amp;author=T+Roumier&amp;author=K+Andreau&amp;author=R+Medema&amp;volume=23&amp;publication_year=2004&amp;pages=2825-2837&amp;pmid=15077146&amp;doi=10.1038/sj.onc.1207528&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11-ijo-60-05-05344">11. <span class="element-citation">Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: A mechanism for avoiding genomic instability. <span><span class="ref-journal">Nat Rev Mol Cell Biol. </span>2011;<span class="ref-vol">12</span>:385–392. doi: 10.1038/nrm3115.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21527953" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fnrm3115" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Mol+Cell+Biol&amp;title=Mitotic+catastrophe:+A+mechanism+for+avoiding+genomic+instability&amp;author=I+Vitale&amp;author=L+Galluzzi&amp;author=M+Castedo&amp;author=G+Kroemer&amp;volume=12&amp;publication_year=2011&amp;pages=385-392&amp;pmid=21527953&amp;doi=10.1038/nrm3115&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12-ijo-60-05-05344">12. <span class="element-citation">Meng X, Bi J, Li Y, Yang S, Zhang Y, Li M, Liu H, Li Y, McDonald ME, Thiel KW, et al. AZD1775 increases sensitivity to olaparib and gemcitabine in cancer cells with p53 mutations. <span><span class="ref-journal">Cancers (Basel) </span>2018;<span class="ref-vol">10</span>:149. doi: 10.3390/cancers10050149.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5977122/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29783721" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fcancers10050149" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancers+(Basel)&amp;title=AZD1775+increases+sensitivity+to+olaparib+and+gemcitabine+in+cancer+cells+with+p53+mutations&amp;author=X+Meng&amp;author=J+Bi&amp;author=Y+Li&amp;author=S+Yang&amp;author=Y+Zhang&amp;volume=10&amp;publication_year=2018&amp;pages=149&amp;doi=10.3390/cancers10050149&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13-ijo-60-05-05344">13. <span class="element-citation">Lin X, Chen D, Zhang C, Zhang X, Li Z, Dong B, Gao J, Shen L. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint. <span><span class="ref-journal">J Exp Clin Cancer Res. </span>2018;<span class="ref-vol">37</span>:129. doi: 10.1186/s13046-018-0790-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6027790/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29954437" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs13046-018-0790-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Clin+Cancer+Res&amp;title=Augmented+antitumor+activity+by+olaparib+plus+AZD1775+in+gastric+cancer+through+disrupting+DNA+damage+repair+pathways+and+DNA+damage+checkpoint&amp;author=X+Lin&amp;author=D+Chen&amp;author=C+Zhang&amp;author=X+Zhang&amp;author=Z+Li&amp;volume=37&amp;publication_year=2018&amp;pages=129&amp;pmid=29954437&amp;doi=10.1186/s13046-018-0790-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14-ijo-60-05-05344">14. <span class="element-citation">Prystowsky MB, Adomako A, Smith RV, Kawachi N, McKimpson W, Atadja P, Chen Q, Schlecht NF, Parish JL, Childs G, et al. The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. <span><span class="ref-journal">J Pathol. </span>2009;<span class="ref-vol">218</span>:467–477. doi: 10.1002/path.2554.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19402126" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fpath.2554" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pathol&amp;title=The+histone+deacetylase+inhibitor+LBH589+inhibits+expression+of+mitotic+genes+causing+G2/M+arrest+and+cell+death+in+head+and+neck+squamous+cell+carcinoma+cell+lines&amp;author=MB+Prystowsky&amp;author=A+Adomako&amp;author=RV+Smith&amp;author=N+Kawachi&amp;author=W+McKimpson&amp;volume=218&amp;publication_year=2009&amp;pages=467-477&amp;pmid=19402126&amp;doi=10.1002/path.2554&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15-ijo-60-05-05344">15. <span class="element-citation">Iglesias-Linares A, Ya&#x000f1;ez-Vico RM, Gonz&#x000e1;lez-Moles MA. Potential role of HDAC inhibitors in cancer therapy: Insights into oral squamous cell carcinoma. <span><span class="ref-journal">Oral Oncol. </span>2010;<span class="ref-vol">46</span>:323–329. doi: 10.1016/j.oraloncology.2010.01.009.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20207580" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.oraloncology.2010.01.009" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oral+Oncol&amp;title=Potential+role+of+HDAC+inhibitors+in+cancer+therapy:+Insights+into+oral+squamous+cell+carcinoma&amp;author=A+Iglesias-Linares&amp;author=RM+Ya&#x000f1;ez-Vico&amp;author=MA+Gonz&#x000e1;lez-Moles&amp;volume=46&amp;publication_year=2010&amp;pages=323-329&amp;pmid=20207580&amp;doi=10.1016/j.oraloncology.2010.01.009&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16-ijo-60-05-05344">16. <span class="element-citation">Lu YS, Kashida Y, Kulp SK, Wang YC, Wang D, Hung JH, Tang M, Lin ZZ, Chen TJ, Cheng AL, et al. Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. <span><span class="ref-journal">Hepatology. </span>2007;<span class="ref-vol">46</span>:1119–1130. doi: 10.1002/hep.21804.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17654699" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fhep.21804" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Efficacy+of+a+novel+histone+deacetylase+inhibitor+in+murine+models+of+hepatocellular+carcinoma&amp;author=YS+Lu&amp;author=Y+Kashida&amp;author=SK+Kulp&amp;author=YC+Wang&amp;author=D+Wang&amp;volume=46&amp;publication_year=2007&amp;pages=1119-1130&amp;pmid=17654699&amp;doi=10.1002/hep.21804&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17-ijo-60-05-05344">17. <span class="element-citation">Ozaki K, Kishikawa F, Tanaka M, Sakamoto T, Tanimura S, Kohno M. Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs. <span><span class="ref-journal">Cancer Sci. </span>2008;<span class="ref-vol">99</span>:376–384. doi: 10.1111/j.1349-7006.2007.00669.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC11158297/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18201278" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1349-7006.2007.00669.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Histone+deacetylase+inhibitors+enhance+the+chemosensitivity+of+tumor+cells+with+cross-resistance+to+a+wide+range+of+DNA-damaging+drugs&amp;author=K+Ozaki&amp;author=F+Kishikawa&amp;author=M+Tanaka&amp;author=T+Sakamoto&amp;author=S+Tanimura&amp;volume=99&amp;publication_year=2008&amp;pages=376-384&amp;pmid=18201278&amp;doi=10.1111/j.1349-7006.2007.00669.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18-ijo-60-05-05344">18. <span class="element-citation">Ji M, Li Z, Lin Z, Chen L. Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer. <span><span class="ref-journal">Am J Cancer Res. </span>2018;<span class="ref-vol">8</span>:2402–2418.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6325471/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30662800" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cancer+Res&amp;title=Antitumor+activity+of+the+novel+HDAC+inhibitor+CUDC-101+combined+with+gemcitabine+in+pancreatic+cancer&amp;author=M+Ji&amp;author=Z+Li&amp;author=Z+Lin&amp;author=L+Chen&amp;volume=8&amp;publication_year=2018&amp;pages=2402-2418&amp;pmid=30662800&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19-ijo-60-05-05344">19. <span class="element-citation">Zhou L, Zhang Y, Chen S, Kmieciak M, Leng Y, Lin H, Rizzo KA, Dumur CI, Ferreira-Gonzalez A, Dai Y, Grant S. A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations. <span><span class="ref-journal">Leukemia. </span>2015;<span class="ref-vol">29</span>:807–818. doi: 10.1038/leu.2014.296.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4387110/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25283841" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fleu.2014.296" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=A+regimen+combining+the+Wee1+inhibitor+AZD1775+with+HDAC+inhibitors+targets+human+acute+myeloid+leukemia+cells+harboring+various+genetic+mutations&amp;author=L+Zhou&amp;author=Y+Zhang&amp;author=S+Chen&amp;author=M+Kmieciak&amp;author=Y+Leng&amp;volume=29&amp;publication_year=2015&amp;pages=807-818&amp;pmid=25283841&amp;doi=10.1038/leu.2014.296&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b20-ijo-60-05-05344">20. <span class="element-citation">Qi W, Zhang W, Edwards H, Chu R, Madlambayan GJ, Taub JW, Wang Z, Wang Y, Li C, Lin H, Ge Y. Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo. <span><span class="ref-journal">Cancer Biol Ther. </span>2015;<span class="ref-vol">16</span>:1784–1793. doi: 10.1080/15384047.2015.1095406.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4847803/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26529495" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F15384047.2015.1095406" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Synergistic+anti-leukemic+interactions+between+panobinostat+and+MK-1775+in+acute+myeloid+leukemia+ex+vivo&amp;author=W+Qi&amp;author=W+Zhang&amp;author=H+Edwards&amp;author=R+Chu&amp;author=GJ+Madlambayan&amp;volume=16&amp;publication_year=2015&amp;pages=1784-1793&amp;pmid=26529495&amp;doi=10.1080/15384047.2015.1095406&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b21-ijo-60-05-05344">21. <span class="element-citation">Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, et al. Replication stress leading to apoptosis within the S-phase contributes to synergism between vorinostat and AZD1775 in HNSCC harboring high-risk TP53 mutation. <span><span class="ref-journal">Clin Cancer Res. </span>2017;<span class="ref-vol">23</span>:6541–6554. doi: 10.1158/1078-0432.CCR-17-0947.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5724758/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28790110" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1078-0432.CCR-17-0947" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Replication+stress+leading+to+apoptosis+within+the+S-phase+contributes+to+synergism+between+vorinostat+and+AZD1775+in+HNSCC+harboring+high-risk+TP53+mutation&amp;author=N+Tanaka&amp;author=AA+Patel&amp;author=L+Tang&amp;author=NL+Silver&amp;author=A+Lindemann&amp;volume=23&amp;publication_year=2017&amp;pages=6541-6554&amp;pmid=28790110&amp;doi=10.1158/1078-0432.CCR-17-0947&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b22-ijo-60-05-05344">22. <span class="element-citation">Hattori K, Takano N, Kazama H, Moriya S, Miyake K, Hiramoto M, Tsukahara K, Miyazawa K. Synergistic non-apoptotic cell death induction by simultaneously targeting proteasome with bortezomib and HDAC6 with ricolinostat in head and neck tumor cells. <span><span class="ref-journal">Oncol Lett. </span>2021;<span class="ref-vol">22</span>:680. doi: 10.3892/ol.2021.12941.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8323012/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34345305" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3892%2Fol.2021.12941" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Lett&amp;title=Synergistic+non-apoptotic+cell+death+induction+by+simultaneously+targeting+proteasome+with+bortezomib+and+HDAC6+with+ricolinostat+in+head+and+neck+tumor+cells&amp;author=K+Hattori&amp;author=N+Takano&amp;author=H+Kazama&amp;author=S+Moriya&amp;author=K+Miyake&amp;volume=22&amp;publication_year=2021&amp;pages=680&amp;pmid=34345305&amp;doi=10.3892/ol.2021.12941&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b23-ijo-60-05-05344">23. <span class="element-citation">Wickstr&#x000f6;m SA, Masoumi KC, Khochbin S, F&#x000e4;ssler R, Massoumi R. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin. <span><span class="ref-journal">Embo J. </span>2010;<span class="ref-vol">29</span>:131–144. doi: 10.1038/emboj.2009.317.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2775896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19893491" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Femboj.2009.317" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Embo+J&amp;title=CYLD+negatively+regulates+cell-cycle+progression+by+inactivating+HDAC6+and+increasing+the+levels+of+acetylated+tubulin&amp;author=SA+Wickstr&#x000f6;m&amp;author=KC+Masoumi&amp;author=S+Khochbin&amp;author=R+F&#x000e4;ssler&amp;author=R+Massoumi&amp;volume=29&amp;publication_year=2010&amp;pages=131-144&amp;pmid=19893491&amp;doi=10.1038/emboj.2009.317&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b24-ijo-60-05-05344">24. <span class="element-citation">Kim IA, No M, Lee JM, Shin JH, Oh JS, Choi EJ, Kim IH, Atadja P, Bernhard EJ. Epigenetic modulation of radiation response in human cancer cells with activated EGFR or HER-2 signaling: Potential role of histone deacetylase 6. <span><span class="ref-journal">Radiother Oncol. </span>2009;<span class="ref-vol">92</span>:125–132. doi: 10.1016/j.radonc.2009.03.008.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19329208" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.radonc.2009.03.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiother+Oncol&amp;title=Epigenetic+modulation+of+radiation+response+in+human+cancer+cells+with+activated+EGFR+or+HER-2+signaling:+Potential+role+of+histone+deacetylase+6&amp;author=IA+Kim&amp;author=M+No&amp;author=JM+Lee&amp;author=JH+Shin&amp;author=JS+Oh&amp;volume=92&amp;publication_year=2009&amp;pages=125-132&amp;pmid=19329208&amp;doi=10.1016/j.radonc.2009.03.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b25-ijo-60-05-05344">25. <span class="element-citation">Namdar M, Perez G, Ngo L, Marks PA. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2010;<span class="ref-vol">107</span>:20003–20008. doi: 10.1073/pnas.1013754107.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2993347/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21037108" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.1013754107" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Selective+inhibition+of+histone+deacetylase+6+(HDAC6)+induces+DNA+damage+and+sensitizes+transformed+cells+to+anticancer+agents&amp;author=M+Namdar&amp;author=G+Perez&amp;author=L+Ngo&amp;author=PA+Marks&amp;volume=107&amp;publication_year=2010&amp;pages=20003-20008&amp;pmid=21037108&amp;doi=10.1073/pnas.1013754107&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b26-ijo-60-05-05344">26. <span class="element-citation">Wang L, Xiang S, Williams KA, Dong H, Bai W, Nicosia SV, Khochbin S, Bepler G, Zhang X. Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e44265. doi: 10.1371/journal.pone.0044265.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3434198/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22957056" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0044265" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Depletion+of+HDAC6+enhances+cisplatin-induced+DNA+damage+and+apoptosis+in+non-small+cell+lung+cancer+cells&amp;author=L+Wang&amp;author=S+Xiang&amp;author=KA+Williams&amp;author=H+Dong&amp;author=W+Bai&amp;volume=7&amp;publication_year=2012&amp;pages=e44265&amp;pmid=22957056&amp;doi=10.1371/journal.pone.0044265&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b27-ijo-60-05-05344">27. <span class="element-citation">Toriyama K, Takano N, Kokuba H, Kazama H, Moriya S, Hiramoto M, Abe S, Miyazawa K. Azithromycin enhances the cytotoxicity of DNA-damaging drugs via lysosomal membrane permeabilization in lung cancer cells. <span><span class="ref-journal">Cancer Sci. </span>2021;<span class="ref-vol">112</span>:3324–3337. doi: 10.1111/cas.14992.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8353917/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34051014" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fcas.14992" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Azithromycin+enhances+the+cytotoxicity+of+DNA-damaging+drugs+via+lysosomal+membrane+permeabilization+in+lung+cancer+cells&amp;author=K+Toriyama&amp;author=N+Takano&amp;author=H+Kokuba&amp;author=H+Kazama&amp;author=S+Moriya&amp;volume=112&amp;publication_year=2021&amp;pages=3324-3337&amp;pmid=34051014&amp;doi=10.1111/cas.14992&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b28-ijo-60-05-05344">28. <span class="element-citation">Pemble H, Kumar P, van Haren J, Wittmann T. GSK3-mediated CLASP2 phosphorylation modulates kinetochore dynamics. <span><span class="ref-journal">J Cell Sci. </span>2017;<span class="ref-vol">130</span>:1404–1412.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5399784/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28232523" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Sci&amp;title=GSK3-mediated+CLASP2+phosphorylation+modulates+kinetochore+dynamics&amp;author=H+Pemble&amp;author=P+Kumar&amp;author=J+van+Haren&amp;author=T+Wittmann&amp;volume=130&amp;publication_year=2017&amp;pages=1404-1412&amp;pmid=28232523&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b29-ijo-60-05-05344">29. <span class="element-citation">Spangle JM, Ghosh-Choudhury N, Munger K. Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif. <span><span class="ref-journal">J Virol. </span>2012;<span class="ref-vol">86</span>:7466–7472. doi: 10.1128/JVI.00487-12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3416298/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22553330" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1128%2FJVI.00487-12" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Activation+of+cap-dependent+translation+by+mucosal+human+papillomavirus+E6+proteins+is+dependent+on+the+integrity+of+the+LXXLL+binding+motif&amp;author=JM+Spangle&amp;author=N+Ghosh-Choudhury&amp;author=K+Munger&amp;volume=86&amp;publication_year=2012&amp;pages=7466-7472&amp;pmid=22553330&amp;doi=10.1128/JVI.00487-12&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b30-ijo-60-05-05344">30. <span class="element-citation">Szalai P, Engedal N. An image-based assay for high-throughput analysis of cell proliferation and cell death of adherent cells. <span><span class="ref-journal">Bio-protocol. </span>2018;<span class="ref-vol">8</span>:e2835. doi: 10.21769/BioProtoc.2835.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8275286/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34286042" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.21769%2FBioProtoc.2835" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bio-protocol&amp;title=An+image-based+assay+for+high-throughput+analysis+of+cell+proliferation+and+cell+death+of+adherent+cells&amp;author=P+Szalai&amp;author=N+Engedal&amp;volume=8&amp;publication_year=2018&amp;pages=e2835&amp;pmid=34286042&amp;doi=10.21769/BioProtoc.2835&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b31-ijo-60-05-05344">31. <span class="element-citation">Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: Mitotic catastrophe. <span><span class="ref-journal">Cell Death Differ. </span>2008;<span class="ref-vol">15</span>:1153–1162. doi: 10.1038/cdd.2008.47.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18404154" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fcdd.2008.47" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Differ&amp;title=Death+through+a+tragedy:+Mitotic+catastrophe&amp;author=H+Vakifahmetoglu&amp;author=M+Olsson&amp;author=B+Zhivotovsky&amp;volume=15&amp;publication_year=2008&amp;pages=1153-1162&amp;pmid=18404154&amp;doi=10.1038/cdd.2008.47&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b32-ijo-60-05-05344">32. <span class="element-citation">Ghelli Luserna di Ror&#x000e0; A, Cerchione C, Martinelli G, Simonetti G. A WEE1 family business: Regulation of mitosis, cancer progression, and therapeutic target. <span><span class="ref-journal">J Hematol Oncol. </span>2020;<span class="ref-vol">13</span>:126. doi: 10.1186/s13045-020-00959-2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7507691/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32958072" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs13045-020-00959-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hematol+Oncol&amp;title=A+WEE1+family+business:+Regulation+of+mitosis,+cancer+progression,+and+therapeutic+target&amp;author=A+Ghelli+Luserna+di+Ror&#x000e0;&amp;author=C+Cerchione&amp;author=G+Martinelli&amp;author=G+Simonetti&amp;volume=13&amp;publication_year=2020&amp;pages=126&amp;pmid=32958072&amp;doi=10.1186/s13045-020-00959-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b33-ijo-60-05-05344">33. <span class="element-citation">Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, et al. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma. <span><span class="ref-journal">Blood. </span>2012;<span class="ref-vol">119</span>:2579–2589. doi: 10.1182/blood-2011-10-387365.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3337713/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22262760" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1182%2Fblood-2011-10-387365" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Preclinical+activity,+pharmacodynamic,+and+pharmacokinetic+properties+of+a+selective+HDAC6+inhibitor,+ACY-1215,+in+combination+with+bortezomib+in+multiple+myeloma&amp;author=L+Santo&amp;author=T+Hideshima&amp;author=AL+Kung&amp;author=JC+Tseng&amp;author=D+Tamang&amp;volume=119&amp;publication_year=2012&amp;pages=2579-2589&amp;pmid=22262760&amp;doi=10.1182/blood-2011-10-387365&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b34-ijo-60-05-05344">34. <span class="element-citation">Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JP, Bui TN, Vijayaraghavan S, Evans KW, et al. Cyclin E overexpression sensitizes triple-negative breast cancer to Wee1 kinase inhibition. <span><span class="ref-journal">Clin Cancer Res. </span>2018;<span class="ref-vol">24</span>:6594–6610. doi: 10.1158/1078-0432.CCR-18-1446.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6317865/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30181387" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1078-0432.CCR-18-1446" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Cyclin+E+overexpression+sensitizes+triple-negative+breast+cancer+to+Wee1+kinase+inhibition&amp;author=X+Chen&amp;author=KH+Low&amp;author=A+Alexander&amp;author=Y+Jiang&amp;author=C+Karakas&amp;volume=24&amp;publication_year=2018&amp;pages=6594-6610&amp;pmid=30181387&amp;doi=10.1158/1078-0432.CCR-18-1446&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b35-ijo-60-05-05344">35. <span class="element-citation">Young LA, O'Connor LO, de Renty C, Veldman-Jones MH, Dorval T, Wilson Z, Jones DR, Lawson D, Odedra R, Maya-Mendoza A, et al. Differential activity of ATR and WEE1 inhibitors in a highly sensitive subpopulation of DLBCL linked to replication stress. <span><span class="ref-journal">Cancer Res. </span>2019;<span class="ref-vol">79</span>:3762–3775. doi: 10.1158/0008-5472.CAN-18-2480.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31123088" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-18-2480" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Differential+activity+of+ATR+and+WEE1+inhibitors+in+a+highly+sensitive+subpopulation+of+DLBCL+linked+to+replication+stress&amp;author=LA+Young&amp;author=LO+O'Connor&amp;author=C+de+Renty&amp;author=MH+Veldman-Jones&amp;author=T+Dorval&amp;volume=79&amp;publication_year=2019&amp;pages=3762-3775&amp;pmid=31123088&amp;doi=10.1158/0008-5472.CAN-18-2480&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b36-ijo-60-05-05344">36. <span class="element-citation">Do K, Doroshow JH, Kummar S. Wee1 kinase as a target for cancer therapy. <span><span class="ref-journal">Cell Cycle. </span>2013;<span class="ref-vol">12</span>:3159–3164. doi: 10.4161/cc.26062.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3865011/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24013427" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4161%2Fcc.26062" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=Wee1+kinase+as+a+target+for+cancer+therapy&amp;author=K+Do&amp;author=JH+Doroshow&amp;author=S+Kummar&amp;volume=12&amp;publication_year=2013&amp;pages=3159-3164&amp;pmid=24013427&amp;doi=10.4161/cc.26062&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b37-ijo-60-05-05344">37. <span class="element-citation">Cuneo KC, Morgan MA, Sahai V, Schipper MJ, Parsels LA, Parsels JD, Devasia T, Al-Hawaray M, Cho CS, Nathan H, et al. Dose escalation trial of the Wee1 inhibitor Adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer. <span><span class="ref-journal">J Clin Oncol. </span>2019;<span class="ref-vol">37</span>:2643–2650. doi: 10.1200/JCO.19.00730.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7006846/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31398082" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.19.00730" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Dose+escalation+trial+of+the+Wee1+inhibitor+Adavosertib+(AZD1775)+in+combination+with+gemcitabine+and+radiation+for+patients+with+locally+advanced+pancreatic+cancer&amp;author=KC+Cuneo&amp;author=MA+Morgan&amp;author=V+Sahai&amp;author=MJ+Schipper&amp;author=LA+Parsels&amp;volume=37&amp;publication_year=2019&amp;pages=2643-2650&amp;pmid=31398082&amp;doi=10.1200/JCO.19.00730&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b38-ijo-60-05-05344">38. <span class="element-citation">Leijen S, van Geel RM, Sonke GS, de Jong D, Rosenberg EH, Marchetti S, Pluim D, van Werkhoven E, Rose S, Lee MA, et al. Phase II study of WEE1 inhibitor AZD1775 plus carboplatin in patients with TP53-mutated ovarian cancer refractory or resistant to first-line therapy within 3 months. <span><span class="ref-journal">J Clin Oncol. </span>2016;<span class="ref-vol">34</span>:4354–4361. doi: 10.1200/JCO.2016.67.5942.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27998224" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.2016.67.5942" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Phase+II+study+of+WEE1+inhibitor+AZD1775+plus+carboplatin+in+patients+with+TP53-mutated+ovarian+cancer+refractory+or+resistant+to+first-line+therapy+within+3+months&amp;author=S+Leijen&amp;author=RM+van+Geel&amp;author=GS+Sonke&amp;author=D+de+Jong&amp;author=EH+Rosenberg&amp;volume=34&amp;publication_year=2016&amp;pages=4354-4361&amp;pmid=27998224&amp;doi=10.1200/JCO.2016.67.5942&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b39-ijo-60-05-05344">39. <span class="element-citation">Lheureux S, Cabanero M, Cristea MC, Mantia-Smaldone G, Olawaiye A, Ellard S, Weberpals JI, Hendrickson AEW, Fleming GF, Welch S, et al. A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia. <span><span class="ref-journal">J Clin Oncol. </span>2019;<span class="ref-vol">37</span>:5518–5518. doi: 10.1200/JCO.2019.37.15_suppl.5518.</span> [<a href="//doi.org/10.1200%2FJCO.2019.37.15_suppl.5518" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=A+randomized+double-blind+placebo-controlled+phase+II+trial+comparing+gemcitabine+monotherapy+to+gemcitabine+in+combination+with+adavosertib+in+women+with+recurrent,+platinum+resistant+epithelial+ovarian+cancer:+A+trial+of+the+Princess+Margaret,+California,+Chicago+and+Mayo+Phase+II+Consortia&amp;author=S+Lheureux&amp;author=M+Cabanero&amp;author=MC+Cristea&amp;author=G+Mantia-Smaldone&amp;author=A+Olawaiye&amp;volume=37&amp;publication_year=2019&amp;pages=5518-5518&amp;doi=10.1200/JCO.2019.37.15_suppl.5518&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b40-ijo-60-05-05344">40. <span class="element-citation">Oza AM, Estevez-Diz M, Grischke EM, Hall M, Marm&#x000e9; F, Provencher D, Uyar D, Weberpals JI, Wenham RM, Laing N, et al. A Biomarker-enriched, randomized phase II trial of adavosertib (AZD1775) plus paclitaxel and carboplatin for women with platinum-sensitive TP53-mutant ovarian cancer. <span><span class="ref-journal">Clin Cancer Res. </span>2020;<span class="ref-vol">26</span>:4767–4776. doi: 10.1158/1078-0432.CCR-20-0219.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32611648" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1078-0432.CCR-20-0219" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=A+Biomarker-enriched,+randomized+phase+II+trial+of+adavosertib+(AZD1775)+plus+paclitaxel+and+carboplatin+for+women+with+platinum-sensitive+TP53-mutant+ovarian+cancer&amp;author=AM+Oza&amp;author=M+Estevez-Diz&amp;author=EM+Grischke&amp;author=M+Hall&amp;author=F+Marm&#x000e9;&amp;volume=26&amp;publication_year=2020&amp;pages=4767-4776&amp;pmid=32611648&amp;doi=10.1158/1078-0432.CCR-20-0219&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b41-ijo-60-05-05344">41. <span class="element-citation">Liu JF, Xiong N, Campos SM, Wright AA, Krasner C, Schumer S, Horowitz N, Veneris J, Tayob N, Morrissey S, et al. Phase II study of the WEE1 inhibitor adavosertib in recurrent uterine serous carcinoma. <span><span class="ref-journal">J Clin Oncol. </span>2021;<span class="ref-vol">39</span>:1531–1539. doi: 10.1200/JCO.20.03167.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33705205" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1200%2FJCO.20.03167" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Phase+II+study+of+the+WEE1+inhibitor+adavosertib+in+recurrent+uterine+serous+carcinoma&amp;author=JF+Liu&amp;author=N+Xiong&amp;author=SM+Campos&amp;author=AA+Wright&amp;author=C+Krasner&amp;volume=39&amp;publication_year=2021&amp;pages=1531-1539&amp;pmid=33705205&amp;doi=10.1200/JCO.20.03167&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b42-ijo-60-05-05344">42. <span class="element-citation">Ku BM, Bae YH, Koh J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ. Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer. <span><span class="ref-journal">Oncotarget. </span>2017;<span class="ref-vol">8</span>:67526–67537. doi: 10.18632/oncotarget.18728.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5620191/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28978051" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.18632%2Foncotarget.18728" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Mutational+status+of+TP53+defines+the+efficacy+of+Wee1+inhibitor+AZD1775+in+KRAS-mutant+non-small+cell+lung+cancer&amp;author=BM+Ku&amp;author=YH+Bae&amp;author=J+Koh&amp;author=JM+Sun&amp;author=SH+Lee&amp;volume=8&amp;publication_year=2017&amp;pages=67526-67537&amp;pmid=28978051&amp;doi=10.18632/oncotarget.18728&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b43-ijo-60-05-05344">43. <span class="element-citation">Kreahling JM, Foroutan P, Reed D, Martinez G, Razabdouski T, Bui MM, Raghavan M, Letson D, Gillies RJ, Altiok S. Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e57523. doi: 10.1371/journal.pone.0057523.</span> Epub ahead of print. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3592874/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23520471" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0057523" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Wee1+inhibition+by+MK-1775+leads+to+tumor+inhibition+and+enhances+efficacy+of+gemcitabine+in+human+sarcomas&amp;author=JM+Kreahling&amp;author=P+Foroutan&amp;author=D+Reed&amp;author=G+Martinez&amp;author=T+Razabdouski&amp;volume=8&amp;publication_year=2013&amp;pages=e57523&amp;pmid=23520471&amp;doi=10.1371/journal.pone.0057523&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b44-ijo-60-05-05344">44. <span class="element-citation">Moses N, Zhang M, Wu JY, Hu C, Xiang S, Geng X, Chen Y, Bai W, Zhang YW, Bepler G, Zhang XM. HDAC6 regulates radiosensitivity of non-small cell lung cancer by promoting degradation of Chk1. <span><span class="ref-journal">Cells. </span>2020;<span class="ref-vol">9</span>:2237. doi: 10.3390/cells9102237.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7600810/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33020410" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3390%2Fcells9102237" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=HDAC6+regulates+radiosensitivity+of+non-small+cell+lung+cancer+by+promoting+degradation+of+Chk1&amp;author=N+Moses&amp;author=M+Zhang&amp;author=JY+Wu&amp;author=C+Hu&amp;author=S+Xiang&amp;volume=9&amp;publication_year=2020&amp;pages=2237&amp;doi=10.3390/cells9102237&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b45-ijo-60-05-05344">45. <span class="element-citation">Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP. HDAC6 is a microtubule-associated deacetylase. <span><span class="ref-journal">Nature. </span>2002;<span class="ref-vol">417</span>:455–458. doi: 10.1038/417455a.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12024216" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2F417455a" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=HDAC6+is+a+microtubule-associated+deacetylase&amp;author=C+Hubbert&amp;author=A+Guardiola&amp;author=R+Shao&amp;author=Y+Kawaguchi&amp;author=A+Ito&amp;volume=417&amp;publication_year=2002&amp;pages=455-458&amp;pmid=12024216&amp;doi=10.1038/417455a&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b46-ijo-60-05-05344">46. <span class="element-citation">Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M, Toft DO, Pratt WB, Yao TP. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. <span><span class="ref-journal">Mol Cell. </span>2005;<span class="ref-vol">18</span>:601–607. doi: 10.1016/j.molcel.2005.04.021.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15916966" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.molcel.2005.04.021" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=HDAC6+regulates+Hsp90+acetylation+and+chaperone-dependent+activation+of+glucocorticoid+receptor&amp;author=JJ+Kovacs&amp;author=PJ+Murphy&amp;author=S+Gaillard&amp;author=X+Zhao&amp;author=JT+Wu&amp;volume=18&amp;publication_year=2005&amp;pages=601-607&amp;pmid=15916966&amp;doi=10.1016/j.molcel.2005.04.021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b47-ijo-60-05-05344">47. <span class="element-citation">Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. <span><span class="ref-journal">Mol Cell. </span>2007;<span class="ref-vol">27</span>:197–213. doi: 10.1016/j.molcel.2007.05.033.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2684874/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17643370" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.molcel.2007.05.033" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=HDAC6+modulates+cell+motility+by+altering+the+acetylation+level+of+cortactin&amp;author=X+Zhang&amp;author=Z+Yuan&amp;author=Y+Zhang&amp;author=S+Yong&amp;author=A+Salas-Burgos&amp;volume=27&amp;publication_year=2007&amp;pages=197-213&amp;pmid=17643370&amp;doi=10.1016/j.molcel.2007.05.033&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b48-ijo-60-05-05344">48. <span class="element-citation">Lee YS, Lim KH, Guo X, Kawaguchi Y, Gao Y, Barrientos T, Ordentlich P, Wang XF, Counter CM, Yao TP. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. <span><span class="ref-journal">Cancer Res. </span>2008;<span class="ref-vol">68</span>:7561–7569. doi: 10.1158/0008-5472.CAN-08-0188.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2978070/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18794144" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F0008-5472.CAN-08-0188" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=The+cytoplasmic+deacetylase+HDAC6+is+required+for+efficient+oncogenic+tumorigenesis&amp;author=YS+Lee&amp;author=KH+Lim&amp;author=X+Guo&amp;author=Y+Kawaguchi&amp;author=Y+Gao&amp;volume=68&amp;publication_year=2008&amp;pages=7561-7569&amp;pmid=18794144&amp;doi=10.1158/0008-5472.CAN-08-0188&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b49-ijo-60-05-05344">49. <span class="element-citation">Lernoux M, Schnekenburger M, Dicato M, Diederich M. Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways. <span><span class="ref-journal">Pharmacol Res. </span>2018;<span class="ref-vol">129</span>:337–356. doi: 10.1016/j.phrs.2017.11.004.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29133216" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.phrs.2017.11.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Res&amp;title=Anti-cancer+effects+of+naturally+derived+compounds+targeting+histone+deacetylase+6-related+pathways&amp;author=M+Lernoux&amp;author=M+Schnekenburger&amp;author=M+Dicato&amp;author=M+Diederich&amp;volume=129&amp;publication_year=2018&amp;pages=337-356&amp;pmid=29133216&amp;doi=10.1016/j.phrs.2017.11.004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b50-ijo-60-05-05344">50. <span class="element-citation">Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT, Craddock C, Turner BM. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. <span><span class="ref-journal">Leukemia. </span>2005;<span class="ref-vol">19</span>:1751–1759. doi: 10.1038/sj.leu.2403910.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16121216" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsj.leu.2403910" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Histone+deacetylases+in+acute+myeloid+leukaemia+show+a+distinctive+pattern+of+expression+that+changes+selectively+in+response+to+deacetylase+inhibitors&amp;author=CA+Bradbury&amp;author=FL+Khanim&amp;author=R+Hayden&amp;author=CM+Bunce&amp;author=DA+White&amp;volume=19&amp;publication_year=2005&amp;pages=1751-1759&amp;pmid=16121216&amp;doi=10.1038/sj.leu.2403910&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b51-ijo-60-05-05344">51. <span class="element-citation">Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe H, Shibahara T, Tanzawa H. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. <span><span class="ref-journal">Int J Oncol. </span>2006;<span class="ref-vol">29</span>:117–124.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16773191" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Oncol&amp;title=Aberrant+expression+of+histone+deacetylase+6+in+oral+squamous+cell+carcinoma&amp;author=T+Sakuma&amp;author=K+Uzawa&amp;author=T+Onda&amp;author=M+Shiiba&amp;author=H+Yokoe&amp;volume=29&amp;publication_year=2006&amp;pages=117-124&amp;pmid=16773191&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b52-ijo-60-05-05344">52. <span class="element-citation">Bazzaro M, Lin Z, Santillan A, Lee MK, Wang MC, Chan KC, Bristow RE, Mazitschek R, Bradner J, Roden RB. Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor. <span><span class="ref-journal">Clin Cancer Res. </span>2008;<span class="ref-vol">14</span>:7340–7347. doi: 10.1158/1078-0432.CCR-08-0642.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2744414/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19010849" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1158%2F1078-0432.CCR-08-0642" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Ubiquitin+proteasome+system+stress+underlies+synergistic+killing+of+ovarian+cancer+cells+by+bortezomib+and+a+novel+HDAC6+inhibitor&amp;author=M+Bazzaro&amp;author=Z+Lin&amp;author=A+Santillan&amp;author=MK+Lee&amp;author=MC+Wang&amp;volume=14&amp;publication_year=2008&amp;pages=7340-7347&amp;pmid=19010849&amp;doi=10.1158/1078-0432.CCR-08-0642&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b53-ijo-60-05-05344">53. <span class="element-citation">Cao J, Lv W, Wang L, Xu J, Yuan P, Huang S, He Z, Hu J. Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways. <span><span class="ref-journal">Cell Death Dis. </span>2018;<span class="ref-vol">9</span>:817. doi: 10.1038/s41419-018-0788-2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6062526/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30050135" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41419-018-0788-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis&amp;title=Ricolinostat+(ACY-1215)+suppresses+proliferation+and+promotes+apoptosis+in+esophageal+squamous+cell+carcinoma+via+miR-30d/PI3K/AKT/mTOR+and+ERK+pathways&amp;author=J+Cao&amp;author=W+Lv&amp;author=L+Wang&amp;author=J+Xu&amp;author=P+Yuan&amp;volume=9&amp;publication_year=2018&amp;pages=817&amp;pmid=30050135&amp;doi=10.1038/s41419-018-0788-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b54-ijo-60-05-05344">54. <span class="element-citation">Kanno K, Kanno S, Nitta H, Uesugi N, Sugai T, Masuda T, Wakabayashi G, Maesawa C. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells. <span><span class="ref-journal">Oncol Rep. </span>2012;<span class="ref-vol">28</span>:867–873. doi: 10.3892/or.2012.1898.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22766642" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3892%2For.2012.1898" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Rep&amp;title=Overexpression+of+histone+deacetylase+6+contributes+to+accelerated+migration+and+invasion+activity+of+hepatocellular+carcinoma+cells&amp;author=K+Kanno&amp;author=S+Kanno&amp;author=H+Nitta&amp;author=N+Uesugi&amp;author=T+Sugai&amp;volume=28&amp;publication_year=2012&amp;pages=867-873&amp;pmid=22766642&amp;doi=10.3892/or.2012.1898&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b55-ijo-60-05-05344">55. <span class="element-citation">Chuang MJ, Wu ST, Tang SH, Lai XM, Lai HC, Hsu KH, Sun KH, Sun GH, Chang SY, Yu DS, et al. The HDAC inhibitor LBH589 induces ERK-dependent prometaphase arrest in prostate cancer via HDAC6 inactivation and down-regulation. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e73401. doi: 10.1371/journal.pone.0073401.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3762759/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24023871" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0073401" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=The+HDAC+inhibitor+LBH589+induces+ERK-dependent+prometaphase+arrest+in+prostate+cancer+via+HDAC6+inactivation+and+down-regulation&amp;author=MJ+Chuang&amp;author=ST+Wu&amp;author=SH+Tang&amp;author=XM+Lai&amp;author=HC+Lai&amp;volume=8&amp;publication_year=2013&amp;pages=e73401&amp;pmid=24023871&amp;doi=10.1371/journal.pone.0073401&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b56-ijo-60-05-05344">56. <span class="element-citation">Vicente JJ, Wordeman L. The quantification and regulation of microtubule dynamics in the mitotic spindle. <span><span class="ref-journal">Curr Opin Cell Biol. </span>2019;<span class="ref-vol">60</span>:36–43. doi: 10.1016/j.ceb.2019.03.017.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6756986/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31108428" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ceb.2019.03.017" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Cell+Biol&amp;title=The+quantification+and+regulation+of+microtubule+dynamics+in+the+mitotic+spindle&amp;author=JJ+Vicente&amp;author=L+Wordeman&amp;volume=60&amp;publication_year=2019&amp;pages=36-43&amp;pmid=31108428&amp;doi=10.1016/j.ceb.2019.03.017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b57-ijo-60-05-05344">57. <span class="element-citation">Ling L, Hu F, Ying X, Ge J, Wang Q. HDAC6 inhibition disrupts maturational progression and meiotic apparatus assembly in mouse oocytes. <span><span class="ref-journal">Cell Cycle. </span>2018;<span class="ref-vol">17</span>:550–556. doi: 10.1080/15384101.2017.1329067.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5969567/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28598228" ref="reftype=pubmed&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F15384101.2017.1329067" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=HDAC6+inhibition+disrupts+maturational+progression+and+meiotic+apparatus+assembly+in+mouse+oocytes&amp;author=L+Ling&amp;author=F+Hu&amp;author=X+Ying&amp;author=J+Ge&amp;author=Q+Wang&amp;volume=17&amp;publication_year=2018&amp;pages=550-556&amp;pmid=28598228&amp;doi=10.1080/15384101.2017.1329067&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8997343&amp;issue-id=404422&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">International Journal of Oncology</span> are provided here courtesy of <strong>Spandidos Publications</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8997343/pdf/ijo-60-05-05344.pdf" class="int-view">PDF (2.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8997343/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8997343/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8997343" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8997343%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="u3KaEoLatTSEIqmPltjkRTadSnSGuiYZ0o1ViMtKzFwLfMT4FcLFbes0VSQMG4hI">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8997343%2F&amp;text=Ricolinostat%20enhances%20adavosertib-induced%20mitotic%20catastrophe%20in%20TP53-mutated%20head%20and%20neck%20squamous%20cell%20carcinoma%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8997343%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997343/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8997343/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/35348191/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8997343/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/35348191/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8997343/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8997343/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC8997343/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
